{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/afsarequebal/AlgoAndDS/blob/master/rnnNb.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "bc97d6da",
      "metadata": {
        "id": "bc97d6da"
      },
      "source": [
        "## CS 6120: Predicting Retraction Paper using RNN(LSTM)\n",
        "\n",
        "## Importing the Libraries"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 1,
      "id": "a03450ac",
      "metadata": {
        "id": "a03450ac"
      },
      "outputs": [],
      "source": [
        "import numpy as np\n",
        "import pandas as pd\n",
        "import re\n",
        "import nltk\n",
        "from nltk.corpus import stopwords\n",
        "from nltk.stem import PorterStemmer\n",
        "from nltk.tokenize import word_tokenize\n",
        "import warnings\n",
        "import seaborn as sns\n",
        "import matplotlib.pyplot as plt\n",
        "warnings.filterwarnings(\"ignore\")\n",
        "from sklearn.utils import resample\n",
        "import string\n",
        "import math\n",
        "\n",
        "warnings.filterwarnings(\"ignore\")"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "fc584cc2",
      "metadata": {
        "id": "fc584cc2"
      },
      "source": [
        "## Reading the data\n",
        "\n",
        " "
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 2,
      "id": "3c9ffbf5",
      "metadata": {
        "id": "3c9ffbf5"
      },
      "outputs": [],
      "source": [
        "## Reading the data and removing columns that are not important. \n",
        "df = pd.read_csv('retraction.csv', sep = ',', encoding = 'latin-1', usecols = lambda col: col not in [\"Unnamed: 0\"])\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 3,
      "id": "f7fa8ac0",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 206
        },
        "id": "f7fa8ac0",
        "outputId": "517406e9-e3fc-42b8-9dd4-ec93feec2b34"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "   Reason                                               Text\n",
              "0       0   ./jbc.,,\"Judith Campisi Farzaneh, Terumi Kohw...\n",
              "1       0   ./jbc.,,\"Metformin for type diabetes mellitus...\n",
              "2       0   ./seals ,,\"Clinical Immunology Vol. , No. , A...\n",
              "3       1   ./jbc.,,\"Full Terms & Conditions of access an...\n",
              "4       1   ./ ,,\"A dedicated translation factor controls..."
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-0c3d278e-a0ab-4863-874b-b82b9ae83e14\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Reason</th>\n",
              "      <th>Text</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>0</td>\n",
              "      <td>./jbc.,,\"Judith Campisi Farzaneh, Terumi Kohw...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0</td>\n",
              "      <td>./jbc.,,\"Metformin for type diabetes mellitus...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>0</td>\n",
              "      <td>./seals ,,\"Clinical Immunology Vol. , No. , A...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>1</td>\n",
              "      <td>./jbc.,,\"Full Terms &amp; Conditions of access an...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>1</td>\n",
              "      <td>./ ,,\"A dedicated translation factor controls...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-0c3d278e-a0ab-4863-874b-b82b9ae83e14')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-0c3d278e-a0ab-4863-874b-b82b9ae83e14 button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-0c3d278e-a0ab-4863-874b-b82b9ae83e14');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 3
        }
      ],
      "source": [
        "df.head()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 4,
      "id": "aecf75db",
      "metadata": {
        "id": "aecf75db"
      },
      "outputs": [],
      "source": [
        "## Renaming the columns so that we understand the columns easily.\n",
        "\n",
        "## Rename Reason as \"spam_or_ham\" and Text as \"message\"\n",
        "\n",
        "df = df.rename(columns = {\"Reason\":\"Target\", \"Text\":\"message\"})"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 5,
      "id": "f6fc153c",
      "metadata": {
        "scrolled": false,
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 206
        },
        "id": "f6fc153c",
        "outputId": "5e2ae439-8e0d-42e2-f93d-8f63308aadda"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "   Target                                            message\n",
              "0       0   ./jbc.,,\"Judith Campisi Farzaneh, Terumi Kohw...\n",
              "1       0   ./jbc.,,\"Metformin for type diabetes mellitus...\n",
              "2       0   ./seals ,,\"Clinical Immunology Vol. , No. , A...\n",
              "3       1   ./jbc.,,\"Full Terms & Conditions of access an...\n",
              "4       1   ./ ,,\"A dedicated translation factor controls..."
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-3cd94d21-2472-4612-8dd1-f4d04befe64d\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Target</th>\n",
              "      <th>message</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>0</td>\n",
              "      <td>./jbc.,,\"Judith Campisi Farzaneh, Terumi Kohw...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0</td>\n",
              "      <td>./jbc.,,\"Metformin for type diabetes mellitus...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>0</td>\n",
              "      <td>./seals ,,\"Clinical Immunology Vol. , No. , A...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>1</td>\n",
              "      <td>./jbc.,,\"Full Terms &amp; Conditions of access an...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>1</td>\n",
              "      <td>./ ,,\"A dedicated translation factor controls...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-3cd94d21-2472-4612-8dd1-f4d04befe64d')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-3cd94d21-2472-4612-8dd1-f4d04befe64d button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-3cd94d21-2472-4612-8dd1-f4d04befe64d');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 5
        }
      ],
      "source": [
        "df.head()"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "1749da04",
      "metadata": {
        "id": "1749da04"
      },
      "source": [
        "## Count plot of the output categories: spam or ham\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 6,
      "id": "c152e8a4",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 515
        },
        "id": "c152e8a4",
        "outputId": "7bb4ebc8-f7c3-4315-ae01-39cabd99ef54"
      },
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 864x576 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {
            "needs_background": "light"
          }
        }
      ],
      "source": [
        "plt.figure(figsize = (12,8))\n",
        "sns.countplot(x ='Target', data = df)\n",
        "plt.title(\"Spam Vs. Ham Messages count\", fontsize = 15)\n",
        "plt.show()"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "9b8549f2",
      "metadata": {
        "id": "9b8549f2"
      },
      "source": [
        "## Upsampling the minority class\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 7,
      "id": "80f27192",
      "metadata": {
        "id": "80f27192"
      },
      "outputs": [],
      "source": [
        "from sklearn.utils import resample\n",
        "\n",
        "df_majority = df[df.Target==0]\n",
        "df_minority = df[df.Target==1]\n",
        "\n",
        "spam_upsample = resample(df_minority, replace = True, \n",
        "                        n_samples = df_majority.shape[0],\n",
        "                        random_state = 101)\n",
        "\n",
        "df_upsampled = pd.concat([df_majority, spam_upsample])  \n",
        "df_upsampled = df_upsampled.sample(frac = 1)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 8,
      "id": "6a9329bb",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "6a9329bb",
        "outputId": "17da1b03-a8ca-4bf4-feec-73b312a4b0e5"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "(3202, 2)"
            ]
          },
          "metadata": {},
          "execution_count": 8
        }
      ],
      "source": [
        "df_upsampled[df_upsampled['Target']==1].shape"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 9,
      "id": "bdea8155",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "bdea8155",
        "outputId": "f7405748-5e6a-4d1b-8d9d-d772efe85c5a"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "(3202, 2)"
            ]
          },
          "metadata": {},
          "execution_count": 9
        }
      ],
      "source": [
        "df_upsampled[df_upsampled['Target']==0].shape"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 56,
      "id": "61eb9d01",
      "metadata": {
        "id": "61eb9d01"
      },
      "outputs": [],
      "source": [
        "## Considering 3000 spam and 3000 ham data points\n",
        "spam_data_points_train = df_upsampled[df_upsampled['Target']==1].iloc[:2000]\n",
        "ham_data_points_train = df_upsampled[df_upsampled['Target']==0].iloc[:2000]\n",
        "\n",
        "## Considering the remaining data points for test\n",
        "spam_data_points_test = df_upsampled[df_upsampled['Target']==1].iloc[2000:]\n",
        "ham_data_points_test = df_upsampled[df_upsampled['Target']==0].iloc[2000:]\n",
        "\n",
        "## Concatenate the training ham and spam messages\n",
        "X_train = pd.concat([spam_data_points_train['message'], ham_data_points_train['message']])\n",
        "## Concatenating the training ham and spam outputs\n",
        "y_train = pd.concat([spam_data_points_train['Target'], ham_data_points_train['Target']])\n",
        "\n",
        "## Concatenating the test ham and spam messages\n",
        "X_test = pd.concat([spam_data_points_test['message'], ham_data_points_test['message']])\n",
        "## Concatenating the test ham and spam outputs\n",
        "y_test = pd.concat([spam_data_points_test['Target'], ham_data_points_test['Target']])\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 57,
      "id": "6428047d",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 71
        },
        "id": "6428047d",
        "outputId": "13f3d218-909a-4399-8586-efe7b94ce2bd"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'\\ny_test = y_test.to_numpy()\\na = 0 \\nb = 0\\nfor val in y_train:\\n  if val == 0:\\n    a = a+1\\n  else:\\n    b = b+1\\nprint(a)\\nprint(b)\\nc=0\\nd=0\\nfor val in y_test:\\n  if val == 0:\\n    c = c+1\\n  else:\\n    d = d+1\\nprint(c)\\nprint(d)\\ntype(y_test)\\n'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 57
        }
      ],
      "source": [
        "## Take a look at the total number of classes and their count using '.value_counts()' for y_train and y_test.\n",
        "## Ensure that there are equal number of spam and ham messages. \n",
        "y_train.value_counts()\n",
        "'''\n",
        "y_test = y_test.to_numpy()\n",
        "a = 0 \n",
        "b = 0\n",
        "for val in y_train:\n",
        "  if val == 0:\n",
        "    a = a+1\n",
        "  else:\n",
        "    b = b+1\n",
        "print(a)\n",
        "print(b)\n",
        "c=0\n",
        "d=0\n",
        "for val in y_test:\n",
        "  if val == 0:\n",
        "    c = c+1\n",
        "  else:\n",
        "    d = d+1\n",
        "print(c)\n",
        "print(d)\n",
        "type(y_test)\n",
        "'''"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 58,
      "id": "2beae1d6",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "2beae1d6",
        "outputId": "33fd03c6-020d-43c3-ea69-cf841baf8d00"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "1    1202\n",
              "0    1202\n",
              "Name: Target, dtype: int64"
            ]
          },
          "metadata": {},
          "execution_count": 58
        }
      ],
      "source": [
        "y_test.value_counts()"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "6501699b",
      "metadata": {
        "id": "6501699b"
      },
      "source": [
        "## Pre-process the messages\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 59,
      "id": "2b6fccb8",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "2b6fccb8",
        "outputId": "6f7256c8-581f-42e1-c35a-fa6dcfc10f42"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[nltk_data] Downloading package stopwords to /root/nltk_data...\n",
            "[nltk_data]   Package stopwords is already up-to-date!\n"
          ]
        }
      ],
      "source": [
        "import string\n",
        "import nltk\n",
        "import nltk\n",
        "nltk.download('stopwords')\n",
        "wn = nltk.WordNetLemmatizer()\n",
        "ps = nltk.PorterStemmer()\n",
        "stopword = nltk.corpus.stopwords.words('english')"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 60,
      "id": "bd4ce1e6",
      "metadata": {
        "id": "bd4ce1e6"
      },
      "outputs": [],
      "source": [
        "def clean_message(message):\n",
        "    '''\n",
        "    Input:\n",
        "        message: a string containing a message.\n",
        "    Output:\n",
        "        messages_cleaned: a list of words containing the processed message. \n",
        "\n",
        "    '''\n",
        "    message = message.lower()\n",
        "    message = re.sub(r\"http\\S+\", \"\", message)\n",
        "    message = re.sub(r\"www.\\S+\", \"\", message)\n",
        "    messages_links_removed = \"\".join([char for char in message if char not in string.punctuation])\n",
        "    messages_cleaned = \" \".join([word for word in re.split('\\W+', messages_links_removed)\n",
        "        if word not in stopword])\n",
        "    #text = \" \".join([ps.stem(word) for word in re.split('\\W+', messages_cleaned)])\n",
        "    text = \" \".join([word for word in re.split('\\W+', messages_cleaned)])\n",
        "    return text\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 61,
      "id": "ba2a290d",
      "metadata": {
        "id": "ba2a290d"
      },
      "outputs": [],
      "source": [
        "df[\"message\"] = df.message.map(clean_message)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 62,
      "id": "c314c916",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 178
        },
        "id": "c314c916",
        "outputId": "6dd12ad1-cd53-4175-afb1-65d0d641c94f"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "' seals clinical immunology vol august pp doiclim available online simultaneous presence mucous membrane pemphigoid pemphigus vulgaris molecular characterization autoantibodies naveed sami kailash c bhol ernst h beutner richard w plunkett kristin leiferman c stephen foster razzaque ahmed department oral medicine harvard school dental medicine boston department medicine new england baptist hospital boston massachusetts beutner laboratories buffalo new york immunodermatology laboratory mayo clinic rochester minnesota mass eye ear infirmary boston massachusetts several reports literature describ ing coexistence features pemphigus vul garis pemphigoid patient de scribe patients clinical histological immunopathological features mucous membrane cicatricial pemphigoid time initial diag nosis patients failed respond clinically conventional systemic agents mean period years hence ivig therapy used prior initiating ivig therapy features mucous mem brane pemphigoid pemphigus vulgaris demonstrated various serological tests different assays performed identify molecular charac teristics two autoantibodies twenty five healthy normal individuals patients mucous membrane pemphigoid patients pemphigus vulgaris patients pemphigus foliaceus served controls comparison serological studies indirect immunofluorescence using monkey esophagous substrate sera pa tients demonstrable levels anti intercellular cement substance ics anti keratinocyte cell sur face antibody sera patients salt split skin bound epidermal side split consistent mucous membrane pemphigoid sera patients demonstrated binding kda protein human integrin kda protein desmoglein immunoblot sample sera patients mucous membrane pemphigoid pemphigus vulgaris anti ics antibody subclass subclass characteristic feature associated pathogenic autoantibodies pemphigus vulgaris hence patients dual diagnosis considered confirmed various serological says possible presence two patho genic autoantibodies patients could contributed lack response conventional key words dual diagnosis pemphigus pemphigoid indirect immunofluorescence salt split skin immuno blot analysis igg subclass introduction two common groups mucocutaneous au toimmune blistering diseases pemphigoid pemphigus diseases different clini cal histological immunopathological serological features pemphigoid divided two major groups bul lous pemphigoid predominantly involves skin mu cous membrane cicatricial pemphigoid mmp volves mucosae oral cavity conjunctiva nose larynx esophagus anus genitalia diagnosis confirmed histology immunopathol ogy histological studies biopsies usually demon strate subepithelial separation dense submu cosal inflammatory cell infiltrate direct immunofluorescence dif studies perilesional bi opsies demonstrate smooth linear deposition igg andor along basement membrane zone bmz characteristic mmp com mon form pemphigus pemphigus vulgaris pv pv affects genders equally age onset years lesions typically described flaccid blisters involving skin mucous membranes lesions usually central distribution pv involves oral mucosa commonly mucosae pharynx larynx esophagus conjunctiva vagina penile anal canal also involved pv acantholysis seen suprabasilar part epidermis histology binding igg andor intercellular substance ics upper stratum malphigii observed dif studies various serological studies per copyright academic press rights reproduction form reserved sami et al antibodies characterize include indi rect immunoflourescence iif studies immunblot assay iif using monkey esophagus substrate presence anti basement membrane antibody sera patients suggestive mmp presence antibodies sera pa tients ics keratinocyte cell surface con sidered typical pv iif also done using salt split skin sss technique increases sensitivity detection circulating anti bmz antibodies facilitates differentiating antibodies bind target antigens lamina lucida epider mal side binding antibodies bind target antigens sublamina densa dermal side binding immunoblot assay also used demonstrate presence autoantibodies specific proteins mmp pv studies demonstrated antibodies kda protein human inte grin detected sera mmp patients marker disease binding sera kda protein desmoglein characteristic pa tients pv sera patients binding kda desmoglein protein typical pemphigus foliaceus however simultaneous presence antibody kda protein kda pro tein pv also reported autoan tibodies also demonstrated pathogenic vitro organ cultures vivo models five studies reported simul taneous presence features mmp pv patients hence considered dual diagnosis study de scribed patients clinical histological immunopatholgical features mmp antibodies sera typically seen mmp pv main objective identify characterize molecules autoantibodies bind materials methods study group fifteen patients features mmp pv studied patients initially diagnosed mmp time initial presentation since patients unresponsive conventional sys temic agents developed multiple side effects prolonged use intravenous immunoglobulin ivig therapy considered alternative treat ment modality successful use ivig mmp previously reported prior initiating ivig therapy various serological assays done test presence pathogenic antibodies inclusion criteria patients availability following nosis inclusion study results routine mucosal lesion ii dif biopsies perilesional mucous membranes iii iif studies sera patients using monkey esophagus clinical data gender age onset disease noted patient well following information clinical profile clinical evaluation document involvement skin mucous membranes entire follow period performed referred clinical profile histology features biopsy included level separation presence inflammatory infil trate submucosa direct immunofluorescence dif performed perilesional mucosal tissue every patient acted antibodies human igg igm iga fibrinogen serology studies sera patients evaluated presence autoantibodies components mucosae using several different assays indirect immunofluo rescence using monkey esophagous substrate performed time initial diagnosis prior initiating ivig therapy salt split skin immu noblot assay done addition iif studies indirect immunofluorescence iif using monkey esophagus substrate ii salt split skin iif sss done using sodium chloride separate dermis epi dermis described previously iii igg subclass distribution distribution subclasses anti ics anti bmz autoantibodies sera patients simultaneous mmp pv study group patients pv control analyzed using iif iv imunoblot assay sera patients evaluated immunoblot assay using bo vine gingival lysate substrate presence kda kda proteins control group control group included healthy normal indi viduals mmp pv pf patients diagnosed history physical examination confirmed biopsy immuno membrane pemphigoid pemphigus vulgaris control group manner study group iif using monkey esophagous substrate sss immunoblot assay results relevant information patients pre sented table clinical characterization demographic data seven patients male female mean age onset years range years clinical presentation mmp patients observed mucosal lesions involvement conjunctiva oral mucosa frequently observed four patients presented lesions esoph agus nasal mucosa one patient laryngeal involvement lesions oral cavity nasal esophageal mucosa consisted erosive lesions denuded epithelium ocular lesions consisted severe conjunctival congestion increased lacrimation short ening fornix symblepharon photophobia histology time initial diagnosis patients subepithelial separation dense submucosal flammatory cell infiltrate predominantly lymphohis tiocytic observed direct immunofluorescence time initial diagnosis patients dif staining perilesional mucosa demonstrated smooth linear deposition igg andor along bmz none patients demonstrable deposi tion igg intercellular spaces mucosal tissues serological studies study group indirect immunofluorescence time initial presentation iif assay using monkey esophagus substrate patients low levels anti bmz antibody patients demonstrated presence anti ics anti body detectable levels anti bmz antibodies fig ii prior initiating ivig therapy pa tients iif studies salt split skin detected binding bmz antibodies patients sera epidermal side split fig patient antibody binding observed however patients serum contained anti bmz antibodies iif using monkey esophagus substrate iii igg subclass distribution random test sera patients mmp pv anti ics autoantibody titer primarily subclass sera tested table addition patients serum low titers subclass autoanti body iv immunoblot assay sera patients demonstrated binding kda kda proteins fig none patients sera bound kda protein b control group indirect immunofluorescence sera healthy individuals tested negative anti bmz anti ics antibodies sera patients mmp tested positive anti bmz autoantibodies titer ranging sera patients demonstrated binding epidermal side split using sss sera patients pv pf contained anti ics antibodies none pv pf patients tested positive anti bmz antibodies pv patients anti ics tibody titers ranged patients pf titers ranged igg subclass distribution igg subclass distri bution sera random patients pv control group anti ics antibodies primarily subclass patients low titers subclass pv autoantibodies table immunoblot assay sera mmp patients bound kda protein gingival lysate sera patients pv bound kda protein patients pf bound kda protein binding observed sera normal healthy individuals fig systemic therapy patients dual diag nosis treated multiple systemic therapies prior receiving ivig treatment details therapy provided table duration systemic therapies ranged months years mean sami et al table clinical profile serology treatment outcome follow patients mucous membrane pemphigoid pemphigus vulgaris patient age sex distribution mucosal lesions treatment prior intravenous immunoglobulin ivig duration treatment indirect immunofluorescence using monkey esophagous salt split skin immunoblot assays kda protein kda protein f conjunctiva corticosteroids months ics epidermal positive positive oral cytosine arabinoside bmz esophagus conjunctiva prednisone years ics epidermal positive positive nasal dapsone bmz oral azathioprine esophagus cyclophosphamide methotrexate cyclosporin cytosine arabinoside f conjunctiva prednisone years ics epidermal positive positive nasal dapsone bmz negative oral azathioprine esophagus cyclophosphamide methotrexate cytosine arabinoside f conjunctiva prednisone years ics epidermal positive positive dapsone bmz methotrexate conjunctiva dapsone years ics epidermal positive positive cyclophosphamide bmz negative azathioprine cytosine arabinoside f conjunctiva prednisone years ics epidermal positive positive vaginal dapsone bmz negative azathioprine cyclophosphamide methotrexate doxycycline conjunctiva dapsone year ics epidermal positive positive methotrexate bmz cyclophosphamide cytosine arabinoside tacrolimus f conjunctiva prednisone years ics epidermal positive positive cyclosporine bmz negative methotrexate tacrolimus cyclophosphamide cytosine arabinoside f conjunctiva prednisone years ics epidermal positive positive oral dapsone bmz negative nasal methotrexate larynx esophagous f conjunctiva prednisone months ics epidermal positive positive oral dapsone bmz negative esophagus tacrolimus f oral prednisone years ics epidermal positive positive dapsone bmz oral prednisone years ics epidermal positive positive bmz membrane pemphigoid pemphigus vulgaris discussion report described patients initially presented typical clinical histological dif features mmp mean period years continued active dis ease sera demonstrated features typical mmp pv hence patients described simultaneous presence blistering diseases thus dual diagnosis several reports patients literature features mmp pv patients described report resemble many patients major additional feature study serological diagnosis made basis recent available technologies provide characteristics help molecular identification pa tients patients features mmp pv mean age onset years gender distinction patients disease limited mucosa majority patients involvement conjunctiva oral mucosa ever nasal esophageal laryngeal lesions also observed time initial diagnosis patients demonstrated subepidermal blister rou tine histology linear deposition igg along perilesional bmz dif low levels anti bmz antibodies iif using monkey esophagus substrate features characteristic mmp prior initiating ivig therapy mean period table patient age sex distribution mucosal lesions treatment prior intravenous immunoglobulin ivig du tr f conjunctiva prednisone dapsone cyclophosphamide methotrexate tacrolimus conjunctiva prednisone dapsone tetracycline erythromycin clindamycin niacinamide conjunctiva prednisone dapsone methotrexate cyclophosphamide systemic antibiotics note ics represents levels antibody intercellular cemen ntibody levels years patients detectable anti bmz antibodies iif using monkey esophagus sub strate however sera patients bound epidermal side split skin characteristic mmp iif using sss reported sensitive detection circulating anti bmz tibodies sera patients demon strable levels pv antibodies bound ics keratinocyte cell surface iif using monkey esopha gus immunoblot assay sera pa tients bound simultaneously kda kda proteins bovine gingival lysate study also determined presence igg subclasses anti ics antibody sera patients mmp pv compared control patients pv reported pathogenic autoantibodies pv subclass correlate disease severity activity pathogenicity autoantibodies confirmed vitro organ culture model pas sive transfer model neonatal mice subclass antibodies probably nonpathogenic may account false positive iif tests pv control group patients anti ics antibody predominantly subclass sera patients mmp pv study group anti ics antibody similar subclass supports observation pemphigus autoantibody patients dual diagnosis probably pathogenic hence patients described report two ontinued ion ment indirect immunofluorescence using monkey esophagous salt split skin immunoblot assays kda protein kda protein ears ics epidermal positive positive bmz negative ars ics epidermal positive positive bmz negative ears ics negative positive positive bmz ubstance bmz represents levels anti basement membrane zone c rat eat ye autoantibodies known pathogenic critical ep sami et al issue emerges autoantibodies produced clinical lesions caused dis ease persist order clarify issue sera patients need separated anti bmz fig presence features pemphigus vulgaris mucous fluorescence using monkey esophagus salt split skin sss note binding intercellular substance ics b reacted smooth homogenous binding basement membrane zone bm bodies note binding seen ics bmz sss rea epidermal side sss e sss reacted serum patients sss f reacted normal human serum note absence anti ics antibody fractions tested organ indicates negative titer culture models andor injection neonatal balbc mice important note substantial time period mean years initial diag brane cicatricial pemphigoid sera indirect immuno reacted serum patients pemphigus vulgaris pv patients mucous membrane pemphigoid mmp note c reacted sera containing mmp pv autoanti serum patients mmp note binding idermolysis bullosa aquisita note binding dermal side binding nosis mmp subsequent serological studies table igg subclass distribution patients mucous membrane pemphigoid pemphigus vulgaris study group clinical diagnosis patients anti intercellular cement substance anti ics antibodies anti basement zone anti bmz antibodies anti intercellular cement substance igg subclass antibodies mucous membrane pemphigoid pemphigus vulgaris mem eru z cted b g r b n membrane pemphigoid pemphigus vulgaris prior initiation ivig therapy patients rebiopsied prior initiation ivig ther apy two reasons first clinical features mucosal lesions similar mmp pv second procedures known exacerbate disease hence possible determine exactly mmp patients devel oped serological profile consistent mmp pv possible slow evolutionary process authors realize lack biopsy initiation ivig therapy limitation study positive serological tests indicate features blistering diseases coexist patient observations signif icant importance impact order determine unique uncommon nature serological observations pa tients evaluated sera random patients mucocutaneous blistering diseases using techniques determine whether anti bodies simultaneously present group consisted patients mmp anti bmz anti bodies detected levels antibodies ics within normal limits patients pv pf anti ics antibodies de tected sera patients mmp demonstrated binding kda protein sera pv pa tients bound kda protein sera pa tients pf bound kda protein hence serological features patients study group unique subpopulation patients present majority patients mmp pv group patients described report fig binding pattern test sera study patients mmunoblot assay using bovine gingival lysate lanes mmunoblots sera different study patients prior nitiation ivig therapy note binding kda human ntegrin kda desmoglein proteins lane lot control serum patient mucous membrane cicatricial pemphigoid note binding kda protein lane mmunoblot control serum patient pemphigus vul aris note binding kda protein lane eacted sera bullous pemphigoid patient note binding oth kda kda proteins lane mmunoblot normal human serum used negative control ote absence binding distinct subset observed specific fea tures defining characteristics subset patients reported study phenotypi cally patients clinical profile would resemble either diseases simultaneously known molecular serological features mmp pv therefore would appear two autoimmune diseases targeting organ simultaneously present clear explanation histology dif initially resembling mmp yet serological profile definitive features characteristics mmp pv later course disease reasonable explanation since one lesion biopsied pathologic diag nosis mmp made patients multiple biopsies different stages disease possible histologic immunopathologic fea tures diseases may recognized concept dual diagnosis limited mmp pv several reports coexistence mmp pv autoimmune diseases mmp reported patients systemic lupus er ythematosus sle rheumatoid arthritis pv also reported patients sle sjogrens syndrome multiple sclerosis myasthenia gravis systemic sclerosis polymyositis also several reports patients simultaneous presence two systemic autoim mune diseases confirmed clinically serological studies reports documenting simultaneous occurrence sle rheumatoid ar thritis sle rheumatoid arthritis also reported coexist autoim table igg subclass distribution control group patients pemphigus vulgaris patients anti intercellular cement substance anti ics antibodies anti basement zone anti bmz antibodiesa anti intercellular cement substance anti ics subclass antibodies indicates negative titer sami et al mune diseases including sjogrens syndrome sclero derma myasthenia gravis hashimotos thyroid itis hashimotos thyroiditis also observed patients sjogrens syndrome sclero derma multiple sclerosis graves disease sjogrens syndrome reported patients myasthenia gravis patients presented report also received multiple drugs included high doses systemic corticosteroids conventional immunosup pressive agents mean period years yet patients achieve reasonable satisfac tory control clear information aggressive systemic immunosuppressive treatments ineffective speculate presence two autoimmune diseases could contributing factor patients characteristics mmp pv literature treated high doses systemic corticosteroids immu nosuppressive agents responded failure systemic therapy also reported autoimmune diseases one diagnosis conclusion recommend patients nonresponsive poorly responsive conventional therapies dual diagnosis considered confirmed assays define molecular characteristics autoantibodies references beutner e h lever w f witebsky e jordon r chertock b autoantibodies pemphigus vulgaris j med assoc beutner e h jordan r e chorzaelski p im munopathology pemphigus bullous pemphigoid j invest dermatol nousari h c anhalt g pemphigus bullous pem phigoid lancet ahmed r graham j jordan r e provost pemphigus current concepts ann intern med lever w f pemphigus pemphigoid j acad derma tol fleming e korman n j cicatricial pemphigoid j acad dermatol scully c review mucocutaneous disorders affecting mouth lips ann acad med singapore gammon w r briggmann r inman q queen l l wheeler l e differentiating anti lamina lucida anti sub lamina densa anti bmz antibodies indirect immunofluo rescence sodium chloride separated skin j invest dermatol chan r bhol k c tesavibul n letko e simmons r foster c ahmed r role human integrin conjunctival basement membrane separation possible vitro model ocp invest opthal vis sci amagaii tsunoda k zillikens nagai ni anti desmoglein autoantibody profile j acad derma tol amagai tsunoda k suzuki h nishifuji k koyasu nishikawa use autoantigen knockout mice devel oping active autoimmune disease model pemphigus j clin invest ding x diaz l fairley j giudice g j liu z anti desmoglein antibodies pemphigus vulgaris pathogenic j invest dermatol ahmed r workman anti intercellular substance antibodies arch dermatol cram l griffith r fukuyama k pemphigus like antibodies cicatricial pemphigoid arch dermatol kumar v yarbrough c beutner e complement fixing intercellular antibodies case cicatricial pemphigoid arch dermatol roenigk h h deodhar pemphigus treatment azathioprine arch dermatol buhac j bhol k padilla foster c ahmed r coexistence pemphigus vulgaris ocular cicatricial pem phigoid j acad dermatol foster c ahmed r intravenous immunoglobulin therapy ocular cicatricial pemphigoid preliminary study ophthalmology sobolinski l beutner e kransy et al substrate specificity anti epithelial antibodies pemphigus vulgaris pemphigus foliaceus sera immunofluorescence tests monkey guinea pig esophagus sections j invest dermatol jones c c hamilton r g jordon r e subclass dis tribution human igg auto antibodies pemphigus j clin immunol bernard p prost c aucoutarier p durepaire n denis f bonnetblane j subclass distribution igg auto antibodies cicatricial pemphigoid eba j invest derma tol bhol k natarajan k nagarwalla n mohimen aoki v ahmed r correlation peptide specificity igg subclass pathogenic nonpathogenic autoantibodies pv model autoimmunity proc natl acad sci usa engineer l johnson r bhol k c ahmed r bovine gingiva lysate novel substrate rapid diagnosis mucocu taneous autoimmune vesiculobullous preliminary study exp dermatol de la maza tauber j foster c cataract surgery ocular cicatricial pemphigoid ophthalmology redman r thorne e g cicatricial pemphigoid patient systemic lupus erythematosis arch dermatol spigel g winkelmann r k cicatricial pemphigoid rheumatoid arthritis arch dermatol olsen k e holland e j association ocular cicatricial pemphigoid rheumatoid arthritis cornea peyri j sevrvitje ribera henkes j ferrandiz c cicatricial pemphigoid patient rheumatoid arthritis penicillamine j acad dermatol shuttleworth graham brown r hutchinson p e membrane pemphigoid pemphigus vulgaris patients arthritis report three cases clin exp derma tol spigel g association cicatricial pemphigoid rheuma toid arthritis arch dermatol chan h pemphigus vulgaris associated systemic lupus erythematosis int j dermatol kuchabal kuchabal pandit nashi h k pemphigus vulgaris associated systemic lupus ery thematosis int j dermatol fong p h chan h l systemic lupus erythematosus pemphigus vulgaris arch dermatol russell j g pemphigus sjogrens syndrome mucosal pig mentation acta stomatol int meiner z zlotogorski brautbar c pemphigus associ ated multiple sclerosis clin exp dermatol friedel j jeandel c abensour heid e multiple sclerosis autoimmune skin bullae case pemphigus dermatolgica hamlet k r stevens r gushurst c karabin g cooper k juvenile pemphigus vulgaris associated graves disease j acad dermatol shabbir g hasssan kazmi suhail asthenia gravis pemphigus vulgaris j pak med assoc noguchi nishitani h case myasthenia gravis asso ciated pemphigus vulgaris thymectomy immunological studies review literature rinsho shinkeigaku shapiro jimenez werth v p pemphigus vulgaris induced penicillamine therapy patient systemic sclerosis j acad dermatol katz l nashel j goard c p bauer h pemphi gus vulgaris lymphoma patient scleroderma south med j fischman abeles zanetti weinstein rothfield n f coexistence rheumatoid arthritis systemic lupus erythematosus j rheumatol venegoni c chevallard mele g banafi g car rabba coexistence rheumatoid arthritis systemic lupus erythematosus clin rheumatol brzezinska b graff wroblewska case coexistence rheumatoid arthritis systemic lupus erythematosus pol tyg lek venegoni c chevallard mele g banfi g carrabba coexistence rheumatoid arthritis systemic lupus erythematosus clin rheumatol yamane k shome g p akama suzuki h matsui h matsui kashiwagi h clinical features patients mild systemic erythematosus scand j rheumatol steinberg talal n coexistence sjogrens syndrome systemic lupus erythematosus ann intern med kameda h kuwana hama n kaburaki j homma coexistence serum anti dna topisomerase anti sm antibodies report cases j rheumatol lee c w kwon c w yoo h kim linear scleroderma occurring patient systemic lupus erythe shelkovitz shiloh ehrenfeld schewach millet feinstein coexistence familial systemic erythematosus local scleroderma int j dermatol chorzelski jablonska coexistence lupus erythem atosus scleroderma light immunopathological investi gations acta derm venereol chen h tsai c p lin k p wang j wu z kao k p myasthenia gravis hyperthyroidism thymoma serological evidence systemic lupus erythematosus case report chung hua hsueh tsa chihtaipei killian p j hoffman g coexistence systemic lupus erythematosus myasthenia gravis south med j sanchez de rivera j barbado hernandez f j vasquez rodriguez j j augado garcia puig j viguer garcia moreno j scleroderma traces disseminated lupus erythematosus associated hashimotos thyroiditis pap illary carcinoma thyroid gland med clinbarc horiki moriuchi j takaya uchiyama hoshina inada k inoko h tsuji k ichikawa coexistence systemic sclerosis rheumatoid arthritis five patients clinical immunogenetic features suggest distinct entity arthritis rheum hrycaj p mackiewick coexistence mutilating rheumatoid arthritis progressive sclerosis polycythemia ra case report j rheumatol baron srolovitz h lander p kapusta coex istence rheumatoid arthritis scleroderma case review literature j rheumatol bhettay e kalla coexistence myasthenia gravis seropositive juvenile chronic arthritis clin exp rheumatol leriche n g bell hashimotos thyroiditis polyarthritis possible subset polyarthritis ann rheum dis reiner goldhirsch kaplan e luscieti p pedrinis e noseda g unusual autoimmune neoplastic associated diseases sjogrens syndrome schweiz med wochenschr fryze w obiedzinski r klos coexistence multiple sclerosis myasthenia gravis neurol neurochir pol yasuda nobunaga association myasthenia gravis connective tissue disease role sjogrens syn drome fukuoka igaku zasshi widjaja rademaker j golkel c holstein leifke e wat n graves ophthalmopathy ocular myasthenia ophthalmology wolfe f epidemiology drug treatment failure rheu matoid arthritis baillieres clin rheumatol van de putte l b kroot e j van riel p l c management refractory rheumatoid arthritis rheumatology cohen j carter j l kinkel r p schwid r therapy relapsing multiple sclerosis treatment nonre received december accepted revision may published online june '"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 62
        }
      ],
      "source": [
        "df.iloc[2,1]"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "a7632fe5",
      "metadata": {
        "id": "a7632fe5"
      },
      "source": [
        "## Count occurence of words"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 64,
      "id": "1a3d3c52",
      "metadata": {
        "id": "1a3d3c52"
      },
      "outputs": [],
      "source": [
        "from collections import Counter\n",
        "\n",
        "#Count unique words\n",
        "def counter_word(text_col):\n",
        "    count = Counter()\n",
        "    for text in text_col.values:\n",
        "        for word in text.split():\n",
        "            count[word] += 1\n",
        "    return count\n",
        "\n",
        "counter = counter_word(df.message)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 65,
      "id": "30219bc9",
      "metadata": {
        "id": "30219bc9"
      },
      "outputs": [],
      "source": [
        "num_unique_words = len(counter)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 66,
      "id": "8fcdf170",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "8fcdf170",
        "outputId": "7e387222-a1a9-4d95-e4fb-60638c96d058"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "Counter({'jbcjudith': 1,\n",
              "         'campisi': 29,\n",
              "         'farzaneh': 7,\n",
              "         'terumi': 2,\n",
              "         'kohwi': 12,\n",
              "         'shigematsu': 33,\n",
              "         'oliver': 158,\n",
              "         'bischof': 27,\n",
              "         'sanjeev': 38,\n",
              "         'galande': 6,\n",
              "         'farzin': 3,\n",
              "         'death': 6880,\n",
              "         'syndrome': 3833,\n",
              "         'protein': 32296,\n",
              "         'apoptotic': 3470,\n",
              "         'cell': 59231,\n",
              "         'selective': 2541,\n",
              "         'cleavage': 1695,\n",
              "         'blm': 242,\n",
              "         'bloom': 182,\n",
              "         'degradation': 2850,\n",
              "         'post': 7917,\n",
              "         'translation': 1461,\n",
              "         'modification': 1562,\n",
              "         'synthesis': 4825,\n",
              "         'doi': 6879,\n",
              "         'jbc': 918,\n",
              "         'originally': 841,\n",
              "         'published': 31615,\n",
              "         'online': 5057,\n",
              "         'january': 2701,\n",
              "         'j': 94835,\n",
              "         'biol': 10712,\n",
              "         'chem': 9813,\n",
              "         'updated': 1170,\n",
              "         'version': 2594,\n",
              "         'article': 8772,\n",
              "         'affinity': 1723,\n",
              "         'sitesfind': 156,\n",
              "         'articles': 2586,\n",
              "         'minireviews': 156,\n",
              "         'reflections': 738,\n",
              "         'classics': 168,\n",
              "         'similar': 11745,\n",
              "         'topics': 505,\n",
              "         'alerts': 438,\n",
              "         'correction': 1521,\n",
              "         'posted': 343,\n",
              "         'cited': 898,\n",
              "         'choose': 1137,\n",
              "         'jbcs': 160,\n",
              "         'e': 64945,\n",
              "         'mail': 4257,\n",
              "         'alertsclick': 159,\n",
              "         'list': 1832,\n",
              "         'cites': 332,\n",
              "         'references': 7600,\n",
              "         'accessed': 677,\n",
              "         'free': 8358,\n",
              "         'u': 21297,\n",
              "         'c': 91842,\n",
              "         'sf': 1210,\n",
              "         'l': 46024,\n",
              "         'ibrary': 355,\n",
              "         'k': 39097,\n",
              "         'arch': 3275,\n",
              "         'w': 27995,\n",
              "         'jbcorg': 2422,\n",
              "         'ow': 6904,\n",
              "         'nloaded': 4542,\n",
              "         'received': 8207,\n",
              "         'publication': 4509,\n",
              "         'july': 2635,\n",
              "         'revised': 1640,\n",
              "         'form': 8949,\n",
              "         'december': 2205,\n",
              "         'papers': 2059,\n",
              "         'press': 5074,\n",
              "         'bischofi': 1,\n",
              "         'judith': 33,\n",
              "         'life': 7483,\n",
              "         'sciences': 2855,\n",
              "         'division': 1690,\n",
              "         'lawrence': 283,\n",
              "         'berkeley': 190,\n",
              "         'national': 5408,\n",
              "         'laboratory': 3498,\n",
              "         'california': 762,\n",
              "         'department': 6437,\n",
              "         'molecular': 8926,\n",
              "         'medicine': 8071,\n",
              "         'rayne': 1,\n",
              "         'institute': 4586,\n",
              "         'guys': 32,\n",
              "         'kuigs': 1,\n",
              "         'st': 3544,\n",
              "         'thomas': 1311,\n",
              "         'school': 6016,\n",
              "         'kings': 91,\n",
              "         'college': 3626,\n",
              "         'london': 1925,\n",
              "         'united': 1979,\n",
              "         'kingdom': 507,\n",
              "         'bs': 799,\n",
              "         'autosomal': 152,\n",
              "         'recessive': 179,\n",
              "         'disor': 95,\n",
              "         'der': 3379,\n",
              "         'characterized': 2029,\n",
              "         'high': 23672,\n",
              "         'incidence': 4161,\n",
              "         'cancer': 31700,\n",
              "         'genomic': 1673,\n",
              "         'instability': 925,\n",
              "         'defective': 580,\n",
              "         'recq': 21,\n",
              "         'like': 7654,\n",
              "         'helicase': 248,\n",
              "         'presumed': 163,\n",
              "         'function': 17397,\n",
              "         'mammalian': 1575,\n",
              "         'dna': 17605,\n",
              "         'replication': 1514,\n",
              "         'recombination': 568,\n",
              "         'repair': 2137,\n",
              "         'show': 7901,\n",
              "         'related': 11872,\n",
              "         'wrn': 29,\n",
              "         'rapidly': 1407,\n",
              "         'cleaved': 642,\n",
              "         'cells': 89119,\n",
              "         'undergoing': 2038,\n",
              "         'apoptosis': 11436,\n",
              "         'kda': 2191,\n",
              "         'major': 6592,\n",
              "         'fragments': 1129,\n",
              "         'kinetics': 820,\n",
              "         'cleav': 51,\n",
              "         'age': 11457,\n",
              "         'polyadp': 159,\n",
              "         'ribose': 257,\n",
              "         'polymerase': 1468,\n",
              "         'prevented': 938,\n",
              "         'caspase': 4348,\n",
              "         'inhibitor': 6099,\n",
              "         'occur': 2517,\n",
              "         'deficient': 2139,\n",
              "         'moreover': 3422,\n",
              "         'recombinant': 2388,\n",
              "         'vitro': 6955,\n",
              "         'recognition': 1846,\n",
              "         'sequence': 6753,\n",
              "         'verified': 721,\n",
              "         'mutating': 30,\n",
              "         'aspartate': 285,\n",
              "         'glycine': 269,\n",
              "         'showing': 2735,\n",
              "         'mutation': 2324,\n",
              "         'rendered': 165,\n",
              "         'resistant': 2378,\n",
              "         'abolish': 103,\n",
              "         'activity': 23879,\n",
              "         'abolished': 633,\n",
              "         'nuclear': 6667,\n",
              "         'foci': 412,\n",
              "         'association': 6806,\n",
              "         'condensed': 2835,\n",
              "         'insoluble': 273,\n",
              "         'matrix': 5374,\n",
              "         'results': 36125,\n",
              "         'suggest': 5878,\n",
              "         'early': 7285,\n",
              "         'selected': 4655,\n",
              "         'target': 9659,\n",
              "         'execution': 324,\n",
              "         'programmed': 357,\n",
              "         'critical': 4432,\n",
              "         'many': 9058,\n",
              "         'biological': 4320,\n",
              "         'processes': 3619,\n",
              "         'including': 10074,\n",
              "         'tissue': 9039,\n",
              "         'morphogenesis': 167,\n",
              "         'home': 1555,\n",
              "         'ostasis': 8,\n",
              "         'development': 14064,\n",
              "         'immunity': 1144,\n",
              "         'host': 2304,\n",
              "         'defense': 711,\n",
              "         'mech': 484,\n",
              "         'anisms': 96,\n",
              "         'elimination': 485,\n",
              "         'damaged': 510,\n",
              "         'potentially': 1534,\n",
              "         'neoplastic': 371,\n",
              "         'may': 30626,\n",
              "         'cause': 4243,\n",
              "         'exacer': 17,\n",
              "         'bate': 99,\n",
              "         'variety': 2335,\n",
              "         'human': 23109,\n",
              "         'diseases': 3590,\n",
              "         'alzheimers': 329,\n",
              "         'huntingtons': 26,\n",
              "         'autoimmunity': 179,\n",
              "         'dying': 226,\n",
              "         'share': 1282,\n",
              "         'cytological': 64,\n",
              "         'molec': 109,\n",
              "         'ular': 252,\n",
              "         'features': 2909,\n",
              "         'regardless': 720,\n",
              "         'initiating': 416,\n",
              "         'signal': 7505,\n",
              "         'changes': 9351,\n",
              "         'include': 4161,\n",
              "         'cytoplasmic': 1339,\n",
              "         'shrinkage': 157,\n",
              "         'plasma': 5415,\n",
              "         'membrane': 6833,\n",
              "         'blebbing': 85,\n",
              "         'chromatin': 2090,\n",
              "         'condensation': 282,\n",
              "         'mo': 1994,\n",
              "         'lecular': 102,\n",
              "         'level': 15964,\n",
              "         'family': 5688,\n",
              "         'cysteine': 731,\n",
              "         'proteases': 345,\n",
              "         'termed': 386,\n",
              "         'caspases': 541,\n",
              "         'selectively': 613,\n",
              "         'cleaves': 89,\n",
              "         'series': 4236,\n",
              "         'substrates': 1089,\n",
              "         'initiator': 182,\n",
              "         'initiate': 380,\n",
              "         'proteolytic': 413,\n",
              "         'cas': 333,\n",
              "         'cade': 78,\n",
              "         'eventually': 485,\n",
              "         'culminates': 25,\n",
              "         'activation': 16666,\n",
              "         'downstream': 1820,\n",
              "         'stream': 858,\n",
              "         'cleave': 100,\n",
              "         'pro': 6433,\n",
              "         'teins': 499,\n",
              "         'subsequently': 1743,\n",
              "         'activated': 6569,\n",
              "         'deoxyribonucle': 2,\n",
              "         'ase': 251,\n",
              "         'point': 8286,\n",
              "         'imminent': 21,\n",
              "         'recognize': 543,\n",
              "         'four': 9508,\n",
              "         'amino': 3864,\n",
              "         'acid': 11238,\n",
              "         'terminal': 3647,\n",
              "         'highly': 4189,\n",
              "         'proteins': 13531,\n",
              "         'generally': 2604,\n",
              "         'one': 32774,\n",
              "         'specific': 15631,\n",
              "         'sites': 4871,\n",
              "         'within': 10033,\n",
              "         'mediated': 9197,\n",
              "         'lead': 3759,\n",
              "         'either': 10079,\n",
              "         'functional': 6530,\n",
              "         'inactivation': 1142,\n",
              "         'presumably': 572,\n",
              "         'facilitates': 448,\n",
              "         'orderly': 82,\n",
              "         'prominent': 554,\n",
              "         'also': 37178,\n",
              "         'known': 6960,\n",
              "         'yama': 14,\n",
              "         'apopain': 3,\n",
              "         'several': 8241,\n",
              "         'sense': 2220,\n",
              "         'damage': 3944,\n",
              "         'andor': 3441,\n",
              "         'participate': 934,\n",
              "         'identified': 6741,\n",
              "         'atm': 663,\n",
              "         'catalytic': 1300,\n",
              "         'subunit': 1520,\n",
              "         'dependent': 11270,\n",
              "         'kinase': 10109,\n",
              "         'pkcs': 209,\n",
              "         'parp': 843,\n",
              "         'effectively': 1493,\n",
              "         'inactivates': 92,\n",
              "         'cad': 835,\n",
              "         'degrades': 91,\n",
              "         'thus': 12092,\n",
              "         'advance': 615,\n",
              "         'fragmentation': 475,\n",
              "         'ensure': 1547,\n",
              "         'destined': 41,\n",
              "         'inactivate': 119,\n",
              "         'involved': 5876,\n",
              "         'maintaining': 778,\n",
              "         'integrity': 1034,\n",
              "         'thereby': 1505,\n",
              "         'assuring': 25,\n",
              "         'recently': 3630,\n",
              "         'genes': 9338,\n",
              "         'escherichia': 881,\n",
              "         'coli': 2371,\n",
              "         'implicated': 961,\n",
              "         'hu': 1744,\n",
              "         'man': 1884,\n",
              "         'encodes': 497,\n",
              "         'participates': 195,\n",
              "         'homologous': 570,\n",
              "         'suppresses': 739,\n",
              "         'illegitimate': 11,\n",
              "         'combination': 5786,\n",
              "         'least': 6393,\n",
              "         'five': 5346,\n",
              "         'recql': 1,\n",
              "         'among': 8161,\n",
              "         'first': 17670,\n",
              "         'linked': 2497,\n",
              "         'hereditary': 155,\n",
              "         'disease': 15591,\n",
              "         'defects': 1457,\n",
              "         'blooms': 45,\n",
              "         'disorder': 2014,\n",
              "         'char': 365,\n",
              "         'acterized': 59,\n",
              "         'multiple': 6594,\n",
              "         'abnormalities': 792,\n",
              "         'immunodefi': 24,\n",
              "         'ciency': 234,\n",
              "         'pre': 6672,\n",
              "         'natal': 90,\n",
              "         'growth': 15965,\n",
              "         'retardation': 211,\n",
              "         'primary': 10247,\n",
              "         'occurs': 2346,\n",
              "         'third': 3891,\n",
              "         'decade': 371,\n",
              "         'work': 9565,\n",
              "         'supported': 3832,\n",
              "         'marie': 202,\n",
              "         'curie': 84,\n",
              "         'fellowship': 257,\n",
              "         'b': 71096,\n",
              "         'institutes': 692,\n",
              "         'health': 10884,\n",
              "         'grants': 778,\n",
              "         'energy': 6836,\n",
              "         'contract': 937,\n",
              "         'de': 20085,\n",
              "         'university': 17190,\n",
              "         'cali': 26,\n",
              "         'fornia': 7,\n",
              "         'costs': 2500,\n",
              "         'defrayed': 297,\n",
              "         'part': 7422,\n",
              "         'payment': 976,\n",
              "         'page': 4075,\n",
              "         'charges': 477,\n",
              "         'must': 4288,\n",
              "         'therefore': 10852,\n",
              "         'hereby': 1425,\n",
              "         'marked': 1745,\n",
              "         'advertisement': 502,\n",
              "         'accordance': 1249,\n",
              "         'usc': 326,\n",
              "         'section': 4631,\n",
              "         'solely': 626,\n",
              "         'indicate': 5294,\n",
              "         'fact': 3756,\n",
              "         'authors': 12796,\n",
              "         'contributed': 959,\n",
              "         'equally': 933,\n",
              "         'present': 11783,\n",
              "         'address': 3172,\n",
              "         'unite': 28,\n",
              "         'recombinaison': 1,\n",
              "         'et': 69948,\n",
              "         'expression': 37039,\n",
              "         'genetique': 4,\n",
              "         'departement': 2,\n",
              "         'sida': 4,\n",
              "         'retrovirus': 226,\n",
              "         'institut': 168,\n",
              "         'pasteur': 93,\n",
              "         'rue': 79,\n",
              "         'du': 2923,\n",
              "         'docteur': 4,\n",
              "         'roux': 119,\n",
              "         'paris': 690,\n",
              "         'cedex': 109,\n",
              "         'france': 804,\n",
              "         'correspondence': 1981,\n",
              "         'addressed': 1611,\n",
              "         'bldg': 40,\n",
              "         'rm': 2008,\n",
              "         'cyclotron': 17,\n",
              "         'rd': 2270,\n",
              "         'ca': 6960,\n",
              "         'tel': 1190,\n",
              "         'fax': 1327,\n",
              "         'jcampisilblgov': 1,\n",
              "         'abbreviations': 772,\n",
              "         'used': 36758,\n",
              "         'deoxyribonu': 5,\n",
              "         'clease': 8,\n",
              "         'ac': 10076,\n",
              "         'devd': 130,\n",
              "         'cho': 1134,\n",
              "         'acetyl': 602,\n",
              "         'asp': 250,\n",
              "         'glu': 507,\n",
              "         'val': 398,\n",
              "         'aldehyde': 175,\n",
              "         'dapi': 443,\n",
              "         'diamidino': 115,\n",
              "         'phenyl': 314,\n",
              "         'indole': 94,\n",
              "         'pk': 683,\n",
              "         'pendent': 343,\n",
              "         'gst': 1988,\n",
              "         'glutathione': 909,\n",
              "         'transferase': 527,\n",
              "         'polyacryl': 29,\n",
              "         'amide': 230,\n",
              "         'gel': 3393,\n",
              "         'electrophoresis': 1008,\n",
              "         'poly': 938,\n",
              "         'adp': 456,\n",
              "         'pbs': 3506,\n",
              "         'phosphate': 2481,\n",
              "         'buffered': 1130,\n",
              "         'saline': 3039,\n",
              "         'pcr': 7913,\n",
              "         'chain': 4239,\n",
              "         'reaction': 5866,\n",
              "         'pml': 425,\n",
              "         'myelocytic': 7,\n",
              "         'leukemia': 1982,\n",
              "         'tlck': 9,\n",
              "         'tosyl': 9,\n",
              "         'lysine': 627,\n",
              "         'chloromethyl': 24,\n",
              "         'ketone': 96,\n",
              "         'ws': 564,\n",
              "         'werner': 96,\n",
              "         'zvad': 54,\n",
              "         'fmk': 277,\n",
              "         'tyr': 382,\n",
              "         'ala': 494,\n",
              "         'fluorom': 1,\n",
              "         'ethyl': 363,\n",
              "         'bp': 3601,\n",
              "         'base': 3011,\n",
              "         'pairs': 1206,\n",
              "         'kb': 2135,\n",
              "         'kilobases': 13,\n",
              "         'tnf': 3593,\n",
              "         'tumor': 11973,\n",
              "         'necrosis': 1436,\n",
              "         'factor': 14399,\n",
              "         'journal': 23503,\n",
              "         'chemistry': 3059,\n",
              "         'vol': 8959,\n",
              "         'issue': 5922,\n",
              "         'april': 2936,\n",
              "         'pp': 9348,\n",
              "         'printed': 504,\n",
              "         'usa': 7893,\n",
              "         'paper': 13042,\n",
              "         'available': 7515,\n",
              "         'line': 7778,\n",
              "         'individuals': 3456,\n",
              "         'hypermutable': 2,\n",
              "         'accumu': 112,\n",
              "         'late': 2389,\n",
              "         'chromatid': 32,\n",
              "         'gaps': 263,\n",
              "         'breaks': 318,\n",
              "         'prominently': 101,\n",
              "         'numer': 163,\n",
              "         'ous': 391,\n",
              "         'sister': 82,\n",
              "         'exchanges': 149,\n",
              "         'localizes': 130,\n",
              "         'discrete': 835,\n",
              "         'nd': 3134,\n",
              "         'bodies': 913,\n",
              "         'contain': 1581,\n",
              "         'recombinationrecombinational': 1,\n",
              "         'sociate': 7,\n",
              "         'putative': 1112,\n",
              "         'ionizing': 165,\n",
              "         'radiation': 2714,\n",
              "         'attributes': 608,\n",
              "         'cellular': 5767,\n",
              "         'phenotypes': 688,\n",
              "         'important': 11820,\n",
              "         'importance': 2768,\n",
              "         'stability': 3089,\n",
              "         'asked': 1772,\n",
              "         'whether': 9940,\n",
              "         'targeted': 1733,\n",
              "         'phase': 9794,\n",
              "         'proteolytically': 38,\n",
              "         'single': 10004,\n",
              "         'site': 6880,\n",
              "         'induced': 22432,\n",
              "         'undergo': 794,\n",
              "         'stimuli': 1487,\n",
              "         'identify': 2953,\n",
              "         'responsible': 2203,\n",
              "         'protease': 1162,\n",
              "         'event': 2826,\n",
              "         'abrogate': 76,\n",
              "         'caused': 3862,\n",
              "         'disappearance': 204,\n",
              "         'detachment': 176,\n",
              "         'con': 7396,\n",
              "         'densed': 9,\n",
              "         'experimental': 7989,\n",
              "         'procedures': 3136,\n",
              "         'reagentstosyl': 1,\n",
              "         'leupeptin': 313,\n",
              "         'purchased': 1606,\n",
              "         'roche': 740,\n",
              "         'diagnostics': 312,\n",
              "         'flu': 309,\n",
              "         'oromethyl': 1,\n",
              "         'enzyme': 3679,\n",
              "         'system': 23059,\n",
              "         'products': 5097,\n",
              "         'bd': 1816,\n",
              "         'pharmingen': 306,\n",
              "         'reagents': 906,\n",
              "         'biology': 2928,\n",
              "         'culture': 6118,\n",
              "         'grade': 2912,\n",
              "         'indicated': 8080,\n",
              "         'prepared': 4425,\n",
              "         'according': 9660,\n",
              "         'manufac': 116,\n",
              "         'turers': 74,\n",
              "         'instructions': 1501,\n",
              "         'antibodiesthe': 4,\n",
              "         'purified': 2496,\n",
              "         'rabbit': 2148,\n",
              "         'anti': 17949,\n",
              "         'n': 74167,\n",
              "         'antibodies': 6358,\n",
              "         'described': 12825,\n",
              "         'previously': 7255,\n",
              "         'tubulin': 882,\n",
              "         'ab': 3847,\n",
              "         'oncogene': 1686,\n",
              "         'science': 11178,\n",
              "         'h': 67396,\n",
              "         'santa': 1624,\n",
              "         'cruz': 1575,\n",
              "         'biotechnology': 1415,\n",
              "         'clone': 1048,\n",
              "         'neomarkers': 41,\n",
              "         'fas': 1154,\n",
              "         'ch': 2821,\n",
              "         'mbl': 26,\n",
              "         'international': 7381,\n",
              "         'corp': 335,\n",
              "         'fluorescence': 3036,\n",
              "         'horseradish': 395,\n",
              "         'per': 10995,\n",
              "         'oxidase': 884,\n",
              "         'conjugated': 1550,\n",
              "         'secondary': 4434,\n",
              "         'vector': 5739,\n",
              "         'laboratories': 1098,\n",
              "         'bio': 1696,\n",
              "         'rad': 872,\n",
              "         'induction': 6784,\n",
              "         'necrosiscells': 1,\n",
              "         'obtained': 11348,\n",
              "         'american': 6913,\n",
              "         'type': 19869,\n",
              "         'collection': 2473,\n",
              "         'cultured': 3325,\n",
              "         'standard': 9272,\n",
              "         'conditions': 10021,\n",
              "         'rpmi': 669,\n",
              "         'dulbeccos': 396,\n",
              "         'modified': 3760,\n",
              "         'eagles': 355,\n",
              "         'medium': 10645,\n",
              "         'technologies': 1562,\n",
              "         'inc': 3981,\n",
              "         'fetal': 2080,\n",
              "         'calf': 403,\n",
              "         'serum': 9179,\n",
              "         'induce': 3273,\n",
              "         'jurkat': 572,\n",
              "         'cellsml': 253,\n",
              "         'incubated': 6041,\n",
              "         'ngml': 2387,\n",
              "         'antibody': 9155,\n",
              "         'mm': 19735,\n",
              "         'staurosporine': 112,\n",
              "         'sigma': 2411,\n",
              "         'chemical': 3784,\n",
              "         'co': 9074,\n",
              "         'hela': 1256,\n",
              "         'calbiochem': 291,\n",
              "         'mgml': 2087,\n",
              "         'cycloheximide': 181,\n",
              "         'mcf': 947,\n",
              "         'jur': 10,\n",
              "         'kat': 16,\n",
              "         'washed': 3385,\n",
              "         'suspended': 569,\n",
              "         'lacking': 1063,\n",
              "         'glucose': 4385,\n",
              "         'containing': 8644,\n",
              "         'pyruvate': 187,\n",
              "         'adaptation': 509,\n",
              "         'oligomycin': 89,\n",
              "         'pretreatment': 1086,\n",
              "         'min': 14219,\n",
              "         'followed': 5918,\n",
              "         'incubation': 2653,\n",
              "         'without': 11012,\n",
              "         'intracellular': 2811,\n",
              "         'atp': 2832,\n",
              "         'levels': 20233,\n",
              "         'determined': 8171,\n",
              "         'using': 39176,\n",
              "         'commercial': 1329,\n",
              "         'kit': 2453,\n",
              "         'fl': 1038,\n",
              "         'asc': 80,\n",
              "         'protocol': 5475,\n",
              "         'furnished': 16,\n",
              "         'supplier': 379,\n",
              "         'studies': 37429,\n",
              "         'preincubated': 317,\n",
              "         'concentrations': 5831,\n",
              "         'added': 5095,\n",
              "         'harvested': 1496,\n",
              "         'later': 3041,\n",
              "         'unless': 663,\n",
              "         'noted': 2378,\n",
              "         'otherwise': 1277,\n",
              "         'extracts': 3461,\n",
              "         'total': 19434,\n",
              "         'lysates': 2260,\n",
              "         'western': 7009,\n",
              "         'analysesnuclear': 1,\n",
              "         'rapid': 2504,\n",
              "         'salt': 1260,\n",
              "         'extraction': 2527,\n",
              "         'briefly': 1412,\n",
              "         'twice': 2252,\n",
              "         'ice': 1981,\n",
              "         'cold': 2320,\n",
              "         'stored': 1251,\n",
              "         'pellets': 343,\n",
              "         'thawed': 87,\n",
              "         'ml': 9058,\n",
              "         'buffer': 5455,\n",
              "         'dignam': 17,\n",
              "         'al': 68578,\n",
              "         'nacl': 1769,\n",
              "         'glycerol': 1407,\n",
              "         'hepes': 621,\n",
              "         'ph': 7374,\n",
              "         'edta': 1175,\n",
              "         'dithiothreitol': 236,\n",
              "         'phenylmethylsulfonyl': 192,\n",
              "         'fluo': 185,\n",
              "         'ride': 122,\n",
              "         'extract': 2141,\n",
              "         'clarified': 179,\n",
              "         'centrifugation': 954,\n",
              "         'g': 45034,\n",
              "         'lysing': 46,\n",
              "         'sds': 3005,\n",
              "         'sample': 8172,\n",
              "         'dye': 1105,\n",
              "         'detergent': 224,\n",
              "         'compatible': 346,\n",
              "         'assay': 7741,\n",
              "         'mg': 12252,\n",
              "         'separated': 1839,\n",
              "         'gradient': 1286,\n",
              "         'analyzed': 6442,\n",
              "         'blotting': 1813,\n",
              "         'detected': 5866,\n",
              "         'chemilumines': 27,\n",
              "         'cence': 278,\n",
              "         'supersignal': 32,\n",
              "         'west': 1297,\n",
              "         'pico': 44,\n",
              "         'detection': 4513,\n",
              "         'pierce': 448,\n",
              "         'digitonin': 59,\n",
              "         'extractiondigitonin': 1,\n",
              "         'performed': 12473,\n",
              "         'scribed': 400,\n",
              "         'adam': 435,\n",
              "         'pelleted': 186,\n",
              "         'gently': 179,\n",
              "         'resuspended': 766,\n",
              "         'separate': 2029,\n",
              "         'cytosolic': 1108,\n",
              "         'supernatant': 1188,\n",
              "         'pellet': 525,\n",
              "         'removed': 2144,\n",
              "         'precipitating': 50,\n",
              "         'meth': 442,\n",
              "         'anol': 19,\n",
              "         'chloroform': 270,\n",
              "         'precipitate': 267,\n",
              "         'solubilized': 169,\n",
              "         'immunofluorescencejurkat': 1,\n",
              "         'collected': 3548,\n",
              "         'cytospin': 39,\n",
              "         'fixed': 9177,\n",
              "         'stained': 2811,\n",
              "         'room': 3000,\n",
              "         'temperature': 8350,\n",
              "         'slides': 813,\n",
              "         'mounted': 469,\n",
              "         'vectashield': 38,\n",
              "         'viewed': 751,\n",
              "         'epifluorescence': 50,\n",
              "         'images': 2644,\n",
              "         'captured': 365,\n",
              "         'cooled': 339,\n",
              "         'charge': 1792,\n",
              "         'cou': 123,\n",
              "         'pled': 46,\n",
              "         'device': 2147,\n",
              "         'camera': 435,\n",
              "         'merged': 218,\n",
              "         'canvas': 36,\n",
              "         'deneba': 3,\n",
              "         'blmglutathione': 1,\n",
              "         'fusion': 2206,\n",
              "         'expressed': 8325,\n",
              "         'insect': 279,\n",
              "         'baculoviruses': 8,\n",
              "         'glutathi': 17,\n",
              "         'sepharose': 502,\n",
              "         'cl': 2968,\n",
              "         'resin': 623,\n",
              "         'amersham': 795,\n",
              "         'pharmacia': 261,\n",
              "         'biotech': 366,\n",
              "         'slurry': 206,\n",
              "         'transferred': 1638,\n",
              "         'column': 1994,\n",
              "         'umes': 14,\n",
              "         'plus': 4141,\n",
              "         'nonidet': 188,\n",
              "         'p': 81514,\n",
              "         'volumes': 589,\n",
              "         'eluted': 588,\n",
              "         'tris': 1400,\n",
              "         'hcl': 1114,\n",
              "         'elution': 259,\n",
              "         'migrated': 145,\n",
              "         'bands': 1353,\n",
              "         'silver': 980,\n",
              "         'nm': 7672,\n",
              "         'reactions': 2319,\n",
              "         'terminated': 251,\n",
              "         'adding': 1115,\n",
              "         'equal': 2859,\n",
              "         'volume': 8770,\n",
              "         'directly': 3891,\n",
              "         'assayed': 1040,\n",
              "         'assayhelicase': 1,\n",
              "         'assays': 3466,\n",
              "         'huang': 1686,\n",
              "         'displacement': 992,\n",
              "         'labeled': 2863,\n",
              "         'oligonucleotide': 839,\n",
              "         'partial': 2173,\n",
              "         'duplex': 209,\n",
              "         'unlabeled': 283,\n",
              "         'cooling': 516,\n",
              "         'addition': 9816,\n",
              "         'loading': 2496,\n",
              "         'bromphenol': 31,\n",
              "         'blue': 2198,\n",
              "         'xylene': 112,\n",
              "         'cyanol': 14,\n",
              "         'displaced': 367,\n",
              "         'oligo': 294,\n",
              "         'nucleotide': 1243,\n",
              "         'nondenatur': 2,\n",
              "         'ing': 7908,\n",
              "         'probe': 2131,\n",
              "         'denatured': 196,\n",
              "         'prior': 4030,\n",
              "         'heating': 901,\n",
              "         'generation': 4236,\n",
              "         'mutant': 5172,\n",
              "         'replacement': 1563,\n",
              "         'position': 3791,\n",
              "         'carried': 4128,\n",
              "         'overlapping': 388,\n",
              "         'myc': 1639,\n",
              "         'full': 4542,\n",
              "         'length': 5965,\n",
              "         'cdna': 2730,\n",
              "         'epitope': 353,\n",
              "         'tag': 520,\n",
              "         'digested': 577,\n",
              "         'ecori': 209,\n",
              "         'bamhi': 225,\n",
              "         'fragment': 1396,\n",
              "         'mutagenized': 20,\n",
              "         'subcloned': 207,\n",
              "         'stratagene': 195,\n",
              "         'two': 34693,\n",
              "         'oligonucleotides': 806,\n",
              "         'spanning': 238,\n",
              "         'synthesized': 1344,\n",
              "         'cttcta': 1,\n",
              "         'acggaagtaggttttaataaaagtgatgcc': 1,\n",
              "         'ggcat': 2,\n",
              "         'cacttttattaaaacctacttccgttagaag': 1,\n",
              "         'action': 4555,\n",
              "         'amplify': 316,\n",
              "         'forward': 2099,\n",
              "         'primer': 1745,\n",
              "         'reverse': 3187,\n",
              "         'mixed': 2467,\n",
              "         'molar': 623,\n",
              "         'amplified': 1228,\n",
              "         'primers': 2118,\n",
              "         'product': 5990,\n",
              "         'pbluescriptks': 1,\n",
              "         'sequenced': 348,\n",
              "         'cloned': 1147,\n",
              "         'partially': 1667,\n",
              "         'obtain': 2901,\n",
              "         'coupled': 1608,\n",
              "         'tnt': 84,\n",
              "         'reticulocyte': 67,\n",
              "         'lysate': 789,\n",
              "         'promega': 634,\n",
              "         'methionine': 523,\n",
              "         'redivue': 5,\n",
              "         'untreated': 2134,\n",
              "         'visualized': 978,\n",
              "         'autoradiography': 256,\n",
              "         'apoptosisto': 10,\n",
              "         'determine': 5899,\n",
              "         'initially': 1270,\n",
              "         'well': 15824,\n",
              "         'established': 3350,\n",
              "         'model': 21915,\n",
              "         'duced': 811,\n",
              "         'monoclonal': 1712,\n",
              "         'treated': 16874,\n",
              "         'kim': 2694,\n",
              "         'irving': 37,\n",
              "         'beresten': 4,\n",
              "         'ellis': 207,\n",
              "         'varying': 1067,\n",
              "         'intervals': 1608,\n",
              "         'raised': 775,\n",
              "         'acids': 3365,\n",
              "         'evident': 971,\n",
              "         'progressing': 51,\n",
              "         'near': 2295,\n",
              "         'completion': 754,\n",
              "         'next': 3658,\n",
              "         'fig': 45452,\n",
              "         'see': 10368,\n",
              "         'subsequent': 2478,\n",
              "         'experiments': 8919,\n",
              "         'showed': 12265,\n",
              "         'respec': 513,\n",
              "         'tively': 958,\n",
              "         'striking': 269,\n",
              "         'contrast': 5771,\n",
              "         'likewise': 364,\n",
              "         'component': 3197,\n",
              "         'repairing': 59,\n",
              "         'double': 6497,\n",
              "         'strand': 983,\n",
              "         'nonhomologous': 18,\n",
              "         'end': 7811,\n",
              "         'joining': 371,\n",
              "         'remained': 1534,\n",
              "         'intact': 1268,\n",
              "         'relatively': 3354,\n",
              "         'initiation': 1278,\n",
              "         'coincided': 76,\n",
              "         'hand': 4605,\n",
              "         'although': 9706,\n",
              "         'completely': 2079,\n",
              "         'required': 6698,\n",
              "         'complete': 4605,\n",
              "         'reflect': 1322,\n",
              "         'differences': 8581,\n",
              "         'enzymes': 1693,\n",
              "         'accessibility': 624,\n",
              "         'apo': 433,\n",
              "         'ptotic': 44,\n",
              "         'stable': 3102,\n",
              "         'hours': 6307,\n",
              "         'initia': 32,\n",
              "         'tion': 13818,\n",
              "         'limited': 4096,\n",
              "         'apopto': 205,\n",
              "         'sis': 1020,\n",
              "         'response': 14491,\n",
              "         'cases': 6115,\n",
              "         'frag': 135,\n",
              "         'ment': 4669,\n",
              "         'fate': 466,\n",
              "         'necrotic': 269,\n",
              "         'causes': 2484,\n",
              "         'loss': 7478,\n",
              "         'characteristic': 1960,\n",
              "         'ne': 2211,\n",
              "         'crotic': 2,\n",
              "         'compared': 18543,\n",
              "         'slower': 332,\n",
              "         'times': 7736,\n",
              "         'thereafter': 555,\n",
              "         'resolved': 1586,\n",
              "         'positions': 1083,\n",
              "         'weight': 9799,\n",
              "         'markers': 2483,\n",
              "         'left': 6169,\n",
              "         'autoradiograms': 31,\n",
              "         'approximate': 485,\n",
              "         'weights': 840,\n",
              "         'right': 5374,\n",
              "         'stim': 244,\n",
              "         'uli': 27,\n",
              "         'lysed': 1083,\n",
              "         'nt': 2697,\n",
              "         'ct': 5024,\n",
              "         'alpha': 2066,\n",
              "         'chx': 96,\n",
              "         'panels': 1496,\n",
              "         'sts': 356,\n",
              "         'closed': 1616,\n",
              "         'circles': 456,\n",
              "         'open': 4612,\n",
              "         'ethanol': 1849,\n",
              "         'solvent': 955,\n",
              "         'control': 39706,\n",
              "         'squares': 580,\n",
              "         'shown': 22953,\n",
              "         'percentage': 3580,\n",
              "         'pretreated': 1138,\n",
              "         'given': 9806,\n",
              "         'presence': 9544,\n",
              "         'ern': 141,\n",
              "         'analysis': 41787,\n",
              "         'comparably': 31,\n",
              "         'low': 15677,\n",
              "         'occurred': 2205,\n",
              "         'little': 2493,\n",
              "         'mycin': 99,\n",
              "         'large': 8406,\n",
              "         'extent': 2883,\n",
              "         'inhibits': 3016,\n",
              "         'taken': 4132,\n",
              "         'together': 3764,\n",
              "         'proteolysis': 294,\n",
              "         'identification': 3526,\n",
              "         'blmto': 1,\n",
              "         'inhibitors': 4155,\n",
              "         'serine': 1065,\n",
              "         'lanes': 2127,\n",
              "         'lane': 3446,\n",
              "         'concentration': 7740,\n",
              "         'inhibited': 3073,\n",
              "         'ap': 3680,\n",
              "         'optotic': 16,\n",
              "         'inhibit': 2221,\n",
              "         'moderate': 2576,\n",
              "         'concen': 588,\n",
              "         'trations': 233,\n",
              "         'true': 21809,\n",
              "         'broad': 1105,\n",
              "         'range': 8499,\n",
              "         'ptosis': 187,\n",
              "         'depends': 1422,\n",
              "         ...})"
            ]
          },
          "metadata": {},
          "execution_count": 66
        }
      ],
      "source": [
        "counter"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 67,
      "id": "e6f80c07",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "e6f80c07",
        "outputId": "2ee33200-2aed-4da0-8569-537c798dd531"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[('j', 94835), ('c', 91842), ('cells', 89119), ('p', 81514), ('n', 74167)]"
            ]
          },
          "metadata": {},
          "execution_count": 67
        }
      ],
      "source": [
        "counter.most_common(5)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 71,
      "id": "29fc8faa",
      "metadata": {
        "id": "29fc8faa"
      },
      "outputs": [],
      "source": [
        "#split dataset into training and validatin set\n",
        "'''\n",
        "train_size = int(df.shape[0]*0.8)\n",
        "train_df = df[:train_size]\n",
        "val_df = df[train_size:]\n",
        "\n",
        "#split text and labels\n",
        "train_sentences = train_df.message.to_numpy()\n",
        "train_labels = train_df.Target.to_numpy()\n",
        "val_sentences = val_df.message.to_numpy()\n",
        "val_labels = val_df.Target.to_numpy()\n",
        "'''\n",
        "train_sentences = X_train.to_numpy()\n",
        "train_labels = y_train.to_numpy()\n",
        "val_sentences = X_test.to_numpy()\n",
        "val_labels = y_test.to_numpy()\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 72,
      "id": "1908731f",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 71
        },
        "id": "1908731f",
        "outputId": "35ec6cb5-0101-4273-f5db-4cc72e5646c0"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'\\na = 0 \\nb = 0\\nfor val in train_labels:\\n  if val == 0:\\n    a = a+1\\n  else:\\n    b = b+1\\nprint(a)\\nprint(b)\\nc=0\\nd=0\\nfor val in val_labels:\\n  if val == 0:\\n    c = c+1\\n  else:\\n    d = d+1\\nprint(c)\\nprint(d)\\nprint(type(train_labels))\\nprint(type(train_sentences))\\n'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 72
        }
      ],
      "source": [
        "train_sentences.shape, val_sentences.shape\n",
        "'''\n",
        "a = 0 \n",
        "b = 0\n",
        "for val in train_labels:\n",
        "  if val == 0:\n",
        "    a = a+1\n",
        "  else:\n",
        "    b = b+1\n",
        "print(a)\n",
        "print(b)\n",
        "c=0\n",
        "d=0\n",
        "for val in val_labels:\n",
        "  if val == 0:\n",
        "    c = c+1\n",
        "  else:\n",
        "    d = d+1\n",
        "print(c)\n",
        "print(d)\n",
        "print(type(train_labels))\n",
        "print(type(train_sentences))\n",
        "'''"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 73,
      "id": "39db2c05",
      "metadata": {
        "id": "39db2c05"
      },
      "outputs": [],
      "source": [
        "#Tokenize\n",
        "from tensorflow.keras.preprocessing.text import Tokenizer\n",
        "\n",
        "#vectorize a text corpus each text into a sequence of integers\n",
        "\n",
        "tokenizer = Tokenizer(num_words=num_unique_words)\n",
        "tokenizer.fit_on_texts(train_sentences)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 75,
      "id": "3ee0c4cd",
      "metadata": {
        "id": "3ee0c4cd"
      },
      "outputs": [],
      "source": [
        "word_index = tokenizer.word_index"
      ]
    },
    {
      "cell_type": "raw",
      "id": "005165eb",
      "metadata": {
        "id": "005165eb"
      },
      "source": [
        "print(word_index)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 76,
      "id": "a18fc51c",
      "metadata": {
        "id": "a18fc51c"
      },
      "outputs": [],
      "source": [
        "train_sequences = tokenizer.texts_to_sequences(train_sentences)\n",
        "val_sequences = tokenizer.texts_to_sequences(val_sentences)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 77,
      "id": "725fd3f8",
      "metadata": {
        "id": "725fd3f8"
      },
      "outputs": [],
      "source": [
        "#print(train_sentences[10:15])\n",
        "#print(train_sequences[10:15])\n",
        "max_length = -1\n",
        "for seq in train_sequences:\n",
        "    if len(seq) > max_length:\n",
        "        max_length = len(seq)\n",
        "max_length = 5000"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 78,
      "id": "c456f041",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "c456f041",
        "outputId": "7a2b3f67-a086-435b-e205-427057bfc98e"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "((4000, 5000), (2404, 5000))"
            ]
          },
          "metadata": {},
          "execution_count": 78
        }
      ],
      "source": [
        "#Pad the sequences to have the same length\n",
        "from tensorflow.keras.preprocessing.sequence import pad_sequences\n",
        "\n",
        "#Max number of words in sequence\n",
        "train_padded = pad_sequences(train_sequences,maxlen = max_length, padding=\"post\", truncating=\"post\")\n",
        "val_padded = pad_sequences(val_sequences, maxlen = max_length, padding=\"post\", truncating=\"post\")\n",
        "train_padded.shape, val_padded.shape\n",
        "#train_sequences.shape, val_sequences.shape"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 79,
      "id": "dd46e047",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "dd46e047",
        "outputId": "bee2205c-ff47-43a5-f5ec-6ce5b1fdd51d"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[ 262 2290    2 ...    0    0    0]\n"
          ]
        }
      ],
      "source": [
        "#print(train_sentences[10])\n",
        "#print(train_sequences[10])\n",
        "print(train_padded[10])"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 80,
      "id": "4cf70afb",
      "metadata": {
        "id": "4cf70afb"
      },
      "outputs": [],
      "source": [
        "reverse_word_index = dict([(idx, word) for (word, idx) in word_index.items()])    \n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 81,
      "id": "f81b55c9",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "f81b55c9",
        "outputId": "d0491b65-7538-4838-9150-7897ceb4b939"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "{1: 'the',\n",
              " 2: 'of',\n",
              " 3: 'and',\n",
              " 4: 'in',\n",
              " 5: 'a',\n",
              " 6: 'to',\n",
              " 7: 'for',\n",
              " 8: 'with',\n",
              " 9: '\\x1a',\n",
              " 10: 'is',\n",
              " 11: 'by',\n",
              " 12: 'was',\n",
              " 13: 'that',\n",
              " 14: 'were',\n",
              " 15: 'as',\n",
              " 16: 'on',\n",
              " 17: 'or',\n",
              " 18: 'j',\n",
              " 19: 'from',\n",
              " 20: 'm',\n",
              " 21: 'at',\n",
              " 22: 'this',\n",
              " 23: 'c',\n",
              " 24: 'are',\n",
              " 25: 's',\n",
              " 26: 'be',\n",
              " 27: 'cells',\n",
              " 28: 'p',\n",
              " 29: 'd',\n",
              " 30: 'n',\n",
              " 31: 'not',\n",
              " 32: 't',\n",
              " 33: 'e',\n",
              " 34: 'h',\n",
              " 35: 'al',\n",
              " 36: 'et',\n",
              " 37: 'an',\n",
              " 38: 'b',\n",
              " 39: 'r',\n",
              " 40: 'we',\n",
              " 41: 'cell',\n",
              " 42: 'i',\n",
              " 43: 'l',\n",
              " 44: 'g',\n",
              " 45: 'patients',\n",
              " 46: 'data',\n",
              " 47: 'study',\n",
              " 48: 'it',\n",
              " 49: 'which',\n",
              " 50: 'no',\n",
              " 51: 'fig',\n",
              " 52: 'have',\n",
              " 53: 'treatment',\n",
              " 54: 'after',\n",
              " 55: 'these',\n",
              " 56: 'k',\n",
              " 57: 'f',\n",
              " 58: 'control',\n",
              " 59: 'analysis',\n",
              " 60: 'can',\n",
              " 61: 'all',\n",
              " 62: 'has',\n",
              " 63: 'group',\n",
              " 64: 'using',\n",
              " 65: 'expression',\n",
              " 66: 'studies',\n",
              " 67: 'also',\n",
              " 68: 'used',\n",
              " 69: 'between',\n",
              " 70: 'results',\n",
              " 71: 'been',\n",
              " 72: 'two',\n",
              " 73: 'w',\n",
              " 74: 'protein',\n",
              " 75: 'only',\n",
              " 76: 'one',\n",
              " 77: 'o',\n",
              " 78: 'effect',\n",
              " 79: 'y',\n",
              " 80: 'may',\n",
              " 81: '\\x1a\\x1a',\n",
              " 82: 'other',\n",
              " 83: 'cancer',\n",
              " 84: 'than',\n",
              " 85: 'but',\n",
              " 86: 'review',\n",
              " 87: 'published',\n",
              " 88: 'more',\n",
              " 89: 'time',\n",
              " 90: 'their',\n",
              " 91: 'figure',\n",
              " 92: 'x',\n",
              " 93: 'v',\n",
              " 94: 'bold',\n",
              " 95: 'there',\n",
              " 96: 'both',\n",
              " 97: 'ci',\n",
              " 98: 'activity',\n",
              " 99: 'effects',\n",
              " 100: 'u',\n",
              " 101: 'high',\n",
              " 102: 'when',\n",
              " 103: 'journal',\n",
              " 104: 'risk',\n",
              " 105: 'human',\n",
              " 106: 'shown',\n",
              " 107: 'true',\n",
              " 108: 'induced',\n",
              " 109: 'different',\n",
              " 110: 'its',\n",
              " 111: 'each',\n",
              " 112: 'mean',\n",
              " 113: 'system',\n",
              " 114: 'such',\n",
              " 115: 'number',\n",
              " 116: 'into',\n",
              " 117: 'research',\n",
              " 118: 'model',\n",
              " 119: 'based',\n",
              " 120: 'table',\n",
              " 121: 'false',\n",
              " 122: 'levels',\n",
              " 123: 'type',\n",
              " 124: 'use',\n",
              " 125: 'mm',\n",
              " 126: 'significant',\n",
              " 127: 'ml',\n",
              " 128: 'de',\n",
              " 129: 'three',\n",
              " 130: 'total',\n",
              " 131: 'our',\n",
              " 132: 'mg',\n",
              " 133: 'compared',\n",
              " 134: 'dna',\n",
              " 135: 'however',\n",
              " 136: 'gene',\n",
              " 137: 'during',\n",
              " 138: 're',\n",
              " 139: 'will',\n",
              " 140: 'then',\n",
              " 141: 'test',\n",
              " 142: 'comparison',\n",
              " 143: 'found',\n",
              " 144: 'cochrane',\n",
              " 145: 'up',\n",
              " 146: 'reported',\n",
              " 147: 'anti',\n",
              " 148: 'had',\n",
              " 149: 'clinical',\n",
              " 150: 'non',\n",
              " 151: 'italic',\n",
              " 152: 'first',\n",
              " 153: 'if',\n",
              " 154: 'they',\n",
              " 155: 'treated',\n",
              " 156: 'new',\n",
              " 157: 'outcome',\n",
              " 158: 'university',\n",
              " 159: 'activation',\n",
              " 160: 'growth',\n",
              " 161: 'methods',\n",
              " 162: 'groups',\n",
              " 163: 'trials',\n",
              " 164: 'information',\n",
              " 165: 'participants',\n",
              " 166: 'method',\n",
              " 167: 'function',\n",
              " 168: 'through',\n",
              " 169: 'mice',\n",
              " 170: 'well',\n",
              " 171: 'specific',\n",
              " 172: 'disease',\n",
              " 173: '\\x1a\\x1a\\x1a',\n",
              " 174: 'level',\n",
              " 175: 'pain',\n",
              " 176: 'some',\n",
              " 177: 'min',\n",
              " 178: 'versus',\n",
              " 179: 'low',\n",
              " 180: 'most',\n",
              " 181: 'increased',\n",
              " 182: 'role',\n",
              " 183: 'response',\n",
              " 184: 'ltd',\n",
              " 185: 'ratio',\n",
              " 186: 'management',\n",
              " 187: 'ii',\n",
              " 188: 'factor',\n",
              " 189: 'org',\n",
              " 190: 'binding',\n",
              " 191: 'because',\n",
              " 192: 'copyright',\n",
              " 193: 'development',\n",
              " 194: 'proteins',\n",
              " 195: 'difference',\n",
              " 196: 'quality',\n",
              " 197: 'wiley',\n",
              " 198: 'could',\n",
              " 199: 'z',\n",
              " 200: 'bolditalic',\n",
              " 201: 'any',\n",
              " 202: 'rate',\n",
              " 203: 'trial',\n",
              " 204: 'tion',\n",
              " 205: 'should',\n",
              " 206: 'john',\n",
              " 207: 'observed',\n",
              " 208: 'value',\n",
              " 209: 'under',\n",
              " 210: 'paper',\n",
              " 211: 'increase',\n",
              " 212: 'same',\n",
              " 213: 'therapy',\n",
              " 214: 'associated',\n",
              " 215: 'following',\n",
              " 216: 'further',\n",
              " 217: 'sons',\n",
              " 218: 'collaboration',\n",
              " 219: 'regular',\n",
              " 220: 'apoptosis',\n",
              " 221: 'described',\n",
              " 222: 'performed',\n",
              " 223: 'higher',\n",
              " 224: 'process',\n",
              " 225: 'years',\n",
              " 226: 'tumor',\n",
              " 227: 'placebo',\n",
              " 228: 'showed',\n",
              " 229: 'thus',\n",
              " 230: 'significantly',\n",
              " 231: 'present',\n",
              " 232: 'positive',\n",
              " 233: 'age',\n",
              " 234: 'over',\n",
              " 235: 'important',\n",
              " 236: 'out',\n",
              " 237: 'related',\n",
              " 238: 'who',\n",
              " 239: 'iv',\n",
              " 240: 'outcomes',\n",
              " 241: 'those',\n",
              " 242: 'similar',\n",
              " 243: 'blood',\n",
              " 244: 'obtained',\n",
              " 245: 'il',\n",
              " 246: 'com',\n",
              " 247: 'days',\n",
              " 248: 'normal',\n",
              " 249: 'fixed',\n",
              " 250: 'did',\n",
              " 251: 'authors',\n",
              " 252: 'included',\n",
              " 253: 'values',\n",
              " 254: 'receptor',\n",
              " 255: 'factors',\n",
              " 256: 'vs',\n",
              " 257: 'dependent',\n",
              " 258: 'so',\n",
              " 259: 'kinase',\n",
              " 260: 'biol',\n",
              " 261: 'acid',\n",
              " 262: 'science',\n",
              " 263: 'drug',\n",
              " 264: 'without',\n",
              " 265: 'dose',\n",
              " 266: 'where',\n",
              " 267: 'controlled',\n",
              " 268: 'due',\n",
              " 269: 'per',\n",
              " 270: 'therefore',\n",
              " 271: 'about',\n",
              " 272: 'day',\n",
              " 273: 'surgery',\n",
              " 274: 'structure',\n",
              " 275: 'small',\n",
              " 276: 'http',\n",
              " 277: 'respectively',\n",
              " 278: 'health',\n",
              " 279: 'medium',\n",
              " 280: 'bone',\n",
              " 281: 'weeks',\n",
              " 282: 'patient',\n",
              " 283: 'single',\n",
              " 284: 'samples',\n",
              " 285: 'change',\n",
              " 286: 'antibody',\n",
              " 287: 'lower',\n",
              " 288: 'interventions',\n",
              " 289: 'although',\n",
              " 290: 'standard',\n",
              " 291: 'presence',\n",
              " 292: 'see',\n",
              " 293: 'within',\n",
              " 294: 'would',\n",
              " 295: 'www',\n",
              " 296: 'four',\n",
              " 297: 'chem',\n",
              " 298: 'phase',\n",
              " 299: 'pp',\n",
              " 300: 'addition',\n",
              " 301: 'co',\n",
              " 302: 'work',\n",
              " 303: 'including',\n",
              " 304: 'whether',\n",
              " 305: 'given',\n",
              " 306: 'size',\n",
              " 307: 'surface',\n",
              " 308: 'conditions',\n",
              " 309: 'primary',\n",
              " 310: 'negative',\n",
              " 311: 'res',\n",
              " 312: 'either',\n",
              " 313: 'before',\n",
              " 314: 'genes',\n",
              " 315: '\\x1a\\x1a\\x1a\\x1a',\n",
              " 316: 'according',\n",
              " 317: 'content',\n",
              " 318: 'tissue',\n",
              " 319: 'evidence',\n",
              " 320: 'molecular',\n",
              " 321: 'complex',\n",
              " 322: 'mediated',\n",
              " 323: 'self',\n",
              " 324: 'vol',\n",
              " 325: 'insulin',\n",
              " 326: 'serum',\n",
              " 327: 'ac',\n",
              " 328: 'case',\n",
              " 329: 'changes',\n",
              " 330: 'potential',\n",
              " 331: 'months',\n",
              " 332: 'long',\n",
              " 333: 'term',\n",
              " 334: 'measured',\n",
              " 335: 'result',\n",
              " 336: 'while',\n",
              " 337: 'signaling',\n",
              " 338: 'doi',\n",
              " 339: 'water',\n",
              " 340: 'design',\n",
              " 341: 'volume',\n",
              " 342: 'support',\n",
              " 343: 'weight',\n",
              " 344: 'order',\n",
              " 345: 'technology',\n",
              " 346: 'many',\n",
              " 347: 'care',\n",
              " 348: 'containing',\n",
              " 349: 'article',\n",
              " 350: 'form',\n",
              " 351: 'solution',\n",
              " 352: 'regulation',\n",
              " 353: 'stress',\n",
              " 354: 'target',\n",
              " 355: 'overall',\n",
              " 356: 'inhibition',\n",
              " 357: 'differences',\n",
              " 358: 'children',\n",
              " 359: 'experiments',\n",
              " 360: 'temperature',\n",
              " 361: 'less',\n",
              " 362: 'current',\n",
              " 363: 'free',\n",
              " 364: 'random',\n",
              " 365: 'range',\n",
              " 366: 'determined',\n",
              " 367: 'medical',\n",
              " 368: 'expressed',\n",
              " 369: 'am',\n",
              " 370: 'against',\n",
              " 371: 'bias',\n",
              " 372: 'sample',\n",
              " 373: 'pcr',\n",
              " 374: 'several',\n",
              " 375: 'point',\n",
              " 376: 'above',\n",
              " 377: 'second',\n",
              " 378: 'social',\n",
              " 379: 'sd',\n",
              " 380: 'performance',\n",
              " 381: 'china',\n",
              " 382: 'large',\n",
              " 383: 'reduced',\n",
              " 384: 'indicated',\n",
              " 385: 'among',\n",
              " 386: 'acute',\n",
              " 387: 'show',\n",
              " 388: 'chronic',\n",
              " 389: 'concentration',\n",
              " 390: 'unclear',\n",
              " 391: 'lines',\n",
              " 392: 'line',\n",
              " 393: 'q',\n",
              " 394: 'like',\n",
              " 395: 'rna',\n",
              " 396: 'very',\n",
              " 397: 'reduction',\n",
              " 398: 'end',\n",
              " 399: 'received',\n",
              " 400: 'experimental',\n",
              " 401: 'ph',\n",
              " 402: 'medicine',\n",
              " 403: 'iii',\n",
              " 404: 'ed',\n",
              " 405: 'oral',\n",
              " 406: 'te',\n",
              " 407: 'follow',\n",
              " 408: 'times',\n",
              " 409: 'active',\n",
              " 410: 'signal',\n",
              " 411: 'assay',\n",
              " 412: 'tr',\n",
              " 413: 'loss',\n",
              " 414: 'flow',\n",
              " 415: 'early',\n",
              " 416: 'set',\n",
              " 417: 'ing',\n",
              " 418: 'phosphorylation',\n",
              " 419: 'heart',\n",
              " 420: 'possible',\n",
              " 421: 'frequency',\n",
              " 422: 'nm',\n",
              " 423: 'state',\n",
              " 424: 'production',\n",
              " 425: 'med',\n",
              " 426: 'akt',\n",
              " 427: 'intervention',\n",
              " 428: 'previously',\n",
              " 429: 'period',\n",
              " 430: 'light',\n",
              " 431: 'part',\n",
              " 432: 'systems',\n",
              " 433: 'site',\n",
              " 434: 'sci',\n",
              " 435: 'mol',\n",
              " 436: 'various',\n",
              " 437: 'available',\n",
              " 438: 'known',\n",
              " 439: 'considered',\n",
              " 440: 'usa',\n",
              " 441: 'references',\n",
              " 442: 'events',\n",
              " 443: 'do',\n",
              " 444: 'vitro',\n",
              " 445: 'pathway',\n",
              " 446: 'region',\n",
              " 447: 'western',\n",
              " 448: 'mechanism',\n",
              " 449: 'con',\n",
              " 450: 'general',\n",
              " 451: 'he',\n",
              " 452: 'network',\n",
              " 453: 'ca',\n",
              " 454: 'criteria',\n",
              " 455: 'formation',\n",
              " 456: 'relative',\n",
              " 457: 'shows',\n",
              " 458: 'international',\n",
              " 459: 'death',\n",
              " 460: 'mrna',\n",
              " 461: 'muscle',\n",
              " 462: 'mouse',\n",
              " 463: 'life',\n",
              " 464: 'lung',\n",
              " 465: 'promoter',\n",
              " 466: 'allocation',\n",
              " 467: 'materials',\n",
              " 468: 'independent',\n",
              " 469: 'knowledge',\n",
              " 470: 'antibodies',\n",
              " 471: 'education',\n",
              " 472: 'evaluation',\n",
              " 473: 'characteristics',\n",
              " 474: 'power',\n",
              " 475: 'induction',\n",
              " 476: 'american',\n",
              " 477: 'nuclear',\n",
              " 478: 'survival',\n",
              " 479: 'association',\n",
              " 480: 'activated',\n",
              " 481: 'sequence',\n",
              " 482: 'domain',\n",
              " 483: 'en',\n",
              " 484: 'pressure',\n",
              " 485: 'membrane',\n",
              " 486: 'year',\n",
              " 487: 'post',\n",
              " 488: 'energy',\n",
              " 489: 'nature',\n",
              " 490: 'inhibitor',\n",
              " 491: 'school',\n",
              " 492: 'identified',\n",
              " 493: 'randomised',\n",
              " 494: 'nf',\n",
              " 495: 'analyzed',\n",
              " 496: 'interaction',\n",
              " 497: 'stage',\n",
              " 498: 'area',\n",
              " 499: 'effective',\n",
              " 500: 'ow',\n",
              " 501: 'scale',\n",
              " 502: 'women',\n",
              " 503: 'required',\n",
              " 504: 'left',\n",
              " 505: 'how',\n",
              " 506: 'whereas',\n",
              " 507: 'double',\n",
              " 508: 'types',\n",
              " 509: 'pro',\n",
              " 510: 'made',\n",
              " 511: 'major',\n",
              " 512: 'functional',\n",
              " 513: 'department',\n",
              " 514: 'vivo',\n",
              " 515: 'findings',\n",
              " 516: 'involved',\n",
              " 517: 'short',\n",
              " 518: 'cases',\n",
              " 519: 'assessment',\n",
              " 520: 'diabetes',\n",
              " 521: 'multiple',\n",
              " 522: 'since',\n",
              " 523: 'transcription',\n",
              " 524: 'individual',\n",
              " 525: 'least',\n",
              " 526: 'wang',\n",
              " 527: 'assessed',\n",
              " 528: 'transfected',\n",
              " 529: 'main',\n",
              " 530: 'report',\n",
              " 531: 'might',\n",
              " 532: 'baseline',\n",
              " 533: 'common',\n",
              " 534: 'body',\n",
              " 535: 'incubated',\n",
              " 536: 'applied',\n",
              " 537: 'heterogeneity',\n",
              " 538: 'resistance',\n",
              " 539: 'being',\n",
              " 540: 'presented',\n",
              " 541: 'pre',\n",
              " 542: 'detected',\n",
              " 543: 'kg',\n",
              " 544: 'culture',\n",
              " 545: 'ability',\n",
              " 546: 'previous',\n",
              " 547: 'infection',\n",
              " 548: '\\x1a\\x1a\\x1a\\x1a\\x1a',\n",
              " 549: 'suggest',\n",
              " 550: 'drugs',\n",
              " 551: 'distribution',\n",
              " 552: 'la',\n",
              " 553: 'demonstrated',\n",
              " 554: 'brain',\n",
              " 555: 'clin',\n",
              " 556: 'concentrations',\n",
              " 557: 'symptoms',\n",
              " 558: 'statistical',\n",
              " 559: 'additional',\n",
              " 560: '\\x1ag',\n",
              " 561: 'sirna',\n",
              " 562: 'reaction',\n",
              " 563: 'cellular',\n",
              " 564: 'decreased',\n",
              " 565: 'does',\n",
              " 566: 'followed',\n",
              " 567: 'students',\n",
              " 568: 'vector',\n",
              " 569: 'means',\n",
              " 570: 'description',\n",
              " 571: 'length',\n",
              " 572: 'li',\n",
              " 573: 'rats',\n",
              " 574: 'even',\n",
              " 575: 'hospital',\n",
              " 576: 'plasma',\n",
              " 577: 'determine',\n",
              " 578: 'combination',\n",
              " 579: 'average',\n",
              " 580: 'liver',\n",
              " 581: 'population',\n",
              " 582: 'us',\n",
              " 583: 'approach',\n",
              " 584: 'right',\n",
              " 585: 'issue',\n",
              " 586: 'derived',\n",
              " 587: 'exposure',\n",
              " 588: 'score',\n",
              " 589: 'analyses',\n",
              " 590: 'product',\n",
              " 591: 'search',\n",
              " 592: 'defined',\n",
              " 593: 'contrast',\n",
              " 594: 'se',\n",
              " 595: 'chinese',\n",
              " 596: 'cycle',\n",
              " 597: 'via',\n",
              " 598: 'status',\n",
              " 599: 'randomized',\n",
              " 600: 'down',\n",
              " 601: 'models',\n",
              " 602: 'initial',\n",
              " 603: 'condition',\n",
              " 604: 'provide',\n",
              " 605: 'family',\n",
              " 606: 'alone',\n",
              " 607: 'protocol',\n",
              " 608: 'them',\n",
              " 609: 'buffer',\n",
              " 610: 'roman',\n",
              " 611: 'cross',\n",
              " 612: 'relationship',\n",
              " 613: 'indicate',\n",
              " 614: 'wild',\n",
              " 615: 'example',\n",
              " 616: 'adverse',\n",
              " 617: 'subjects',\n",
              " 618: 'duration',\n",
              " 619: 'key',\n",
              " 620: 'influence',\n",
              " 621: 'plant',\n",
              " 622: 'efficacy',\n",
              " 623: 'dc',\n",
              " 624: 'full',\n",
              " 625: 'properties',\n",
              " 626: 'theory',\n",
              " 627: 'five',\n",
              " 628: 'stimulation',\n",
              " 629: 'people',\n",
              " 630: 'way',\n",
              " 631: 'van',\n",
              " 632: 'index',\n",
              " 633: 'another',\n",
              " 634: 'corresponding',\n",
              " 635: 'decrease',\n",
              " 636: 'training',\n",
              " 637: 'six',\n",
              " 638: 'developed',\n",
              " 639: '\\x1am',\n",
              " 640: 'cardiac',\n",
              " 641: 'added',\n",
              " 642: 'application',\n",
              " 643: 'examined',\n",
              " 644: 'teaching',\n",
              " 645: 'week',\n",
              " 646: 'author',\n",
              " 647: 'greater',\n",
              " 648: 'problem',\n",
              " 649: 'provided',\n",
              " 650: 'field',\n",
              " 651: 'concealment',\n",
              " 652: 'national',\n",
              " 653: 'sites',\n",
              " 654: 'controls',\n",
              " 655: 'favours',\n",
              " 656: 'parameters',\n",
              " 657: 'engineering',\n",
              " 658: 'recent',\n",
              " 659: 'likely',\n",
              " 660: 'direct',\n",
              " 661: 'ng',\n",
              " 662: 'impact',\n",
              " 663: 'isolated',\n",
              " 664: 'none',\n",
              " 665: 'measures',\n",
              " 666: 'his',\n",
              " 667: 'blot',\n",
              " 668: 'online',\n",
              " 669: 'mir',\n",
              " 670: 'terms',\n",
              " 671: 'calculated',\n",
              " 672: 'press',\n",
              " 673: 'rat',\n",
              " 674: 'mutant',\n",
              " 675: 'injection',\n",
              " 676: 'ab',\n",
              " 677: 'absence',\n",
              " 678: 'failure',\n",
              " 679: 'physical',\n",
              " 680: 'matrix',\n",
              " 681: 'heat',\n",
              " 682: 'ieee',\n",
              " 683: 'center',\n",
              " 684: 'release',\n",
              " 685: 'er',\n",
              " 686: 'rates',\n",
              " 687: 'decision',\n",
              " 688: 'caspase',\n",
              " 689: 'discussion',\n",
              " 690: 'layer',\n",
              " 691: 'side',\n",
              " 692: 'le',\n",
              " 693: 'hours',\n",
              " 694: 'behavior',\n",
              " 695: 'amount',\n",
              " 696: 'here',\n",
              " 697: 'society',\n",
              " 698: 'need',\n",
              " 699: 'calcium',\n",
              " 700: 'synthesis',\n",
              " 701: 'bcl',\n",
              " 702: 'ms',\n",
              " 703: 'practice',\n",
              " 704: 'glucose',\n",
              " 705: 'subgroup',\n",
              " 706: 'activities',\n",
              " 707: 'increases',\n",
              " 708: 'animals',\n",
              " 709: 'algorithm',\n",
              " 710: 'density',\n",
              " 711: 'exposed',\n",
              " 712: 'notes',\n",
              " 713: 'mechanisms',\n",
              " 714: 'strategy',\n",
              " 715: 'breast',\n",
              " 716: 'ma',\n",
              " 717: 'chen',\n",
              " 718: 'section',\n",
              " 719: 'action',\n",
              " 720: 'good',\n",
              " 721: 'better',\n",
              " 722: 'wt',\n",
              " 723: 'proposed',\n",
              " 724: 'ment',\n",
              " 725: 'material',\n",
              " 726: 'experiment',\n",
              " 727: 'staining',\n",
              " 728: 'cost',\n",
              " 729: 'products',\n",
              " 730: 'incidence',\n",
              " 731: 'plus',\n",
              " 732: 'measure',\n",
              " 733: 'publication',\n",
              " 734: 'injury',\n",
              " 735: 'institute',\n",
              " 736: 'open',\n",
              " 737: 'hand',\n",
              " 738: 'zhang',\n",
              " 739: 'mail',\n",
              " 740: 'receptors',\n",
              " 741: 'administration',\n",
              " 742: 'liu',\n",
              " 743: 'blind',\n",
              " 744: 'nloaded',\n",
              " 745: 'secondary',\n",
              " 746: 'combined',\n",
              " 747: 'selected',\n",
              " 748: 'proliferation',\n",
              " 749: 'prepared',\n",
              " 750: 'increasing',\n",
              " 751: 'surgical',\n",
              " 752: 'central',\n",
              " 753: '\\x1ac',\n",
              " 754: 'ar',\n",
              " 755: 'agents',\n",
              " 756: 'procedure',\n",
              " 757: 'series',\n",
              " 758: 'error',\n",
              " 759: 'mortality',\n",
              " 760: 'ra',\n",
              " 761: 'mass',\n",
              " 762: 'treatments',\n",
              " 763: 'local',\n",
              " 764: 'complete',\n",
              " 765: 'panel',\n",
              " 766: 'ad',\n",
              " 767: 'biological',\n",
              " 768: 'species',\n",
              " 769: 'degree',\n",
              " 770: 'detection',\n",
              " 771: 'real',\n",
              " 772: 'critical',\n",
              " 773: 'seen',\n",
              " 774: 'tumors',\n",
              " 775: 'novel',\n",
              " 776: 'much',\n",
              " 777: 'regulated',\n",
              " 778: 'inflammatory',\n",
              " 779: 'introduction',\n",
              " 780: 'ct',\n",
              " 781: 'learning',\n",
              " 782: 'endothelial',\n",
              " 783: 'virus',\n",
              " 784: 'inhibitors',\n",
              " 785: 'abstract',\n",
              " 786: 'ppi',\n",
              " 787: 'points',\n",
              " 788: 'consistent',\n",
              " 789: 'what',\n",
              " 790: 'cm',\n",
              " 791: 'whole',\n",
              " 792: 'rev',\n",
              " 793: 'continued',\n",
              " 794: 'step',\n",
              " 795: 'oxygen',\n",
              " 796: 'must',\n",
              " 797: 'dr',\n",
              " 798: 'problems',\n",
              " 799: 'formula',\n",
              " 800: 'taken',\n",
              " 801: 'wp',\n",
              " 802: 'functions',\n",
              " 803: 'cause',\n",
              " 804: 'improved',\n",
              " 805: 'excluded',\n",
              " 806: 'proc',\n",
              " 807: 'output',\n",
              " 808: 'sensitivity',\n",
              " 809: 'tested',\n",
              " 810: 'environment',\n",
              " 811: 'generation',\n",
              " 812: 'basis',\n",
              " 813: 'software',\n",
              " 814: 'lane',\n",
              " 815: 'make',\n",
              " 816: 'der',\n",
              " 817: 'male',\n",
              " 818: 'clear',\n",
              " 819: 'responses',\n",
              " 820: 'pa',\n",
              " 821: 'fold',\n",
              " 822: 'damage',\n",
              " 823: 'judgement',\n",
              " 824: 'prevention',\n",
              " 825: 'uk',\n",
              " 826: 'internal',\n",
              " 827: 'still',\n",
              " 828: 'variables',\n",
              " 829: 'limited',\n",
              " 830: 'tissues',\n",
              " 831: 'natural',\n",
              " 832: 'enhanced',\n",
              " 833: 'item',\n",
              " 834: 'affect',\n",
              " 835: 'agent',\n",
              " 836: 'terminal',\n",
              " 837: 'position',\n",
              " 838: 'page',\n",
              " 839: 'ex',\n",
              " 840: 'strength',\n",
              " 841: 'improve',\n",
              " 842: 'female',\n",
              " 843: 'revealed',\n",
              " 844: 'highly',\n",
              " 845: 'intensity',\n",
              " 846: 'processing',\n",
              " 847: 'furthermore',\n",
              " 848: 'pathways',\n",
              " 849: 'include',\n",
              " 850: 'infected',\n",
              " 851: 'treat',\n",
              " 852: 'third',\n",
              " 853: 'ap',\n",
              " 854: 'enzyme',\n",
              " 855: 'na',\n",
              " 856: 'differentiation',\n",
              " 857: '\\x1ab',\n",
              " 858: 'severe',\n",
              " 859: 'follows',\n",
              " 860: 'diagnosis',\n",
              " 861: 'pattern',\n",
              " 862: 'amino',\n",
              " 863: 'measurement',\n",
              " 864: 'relevant',\n",
              " 865: 'plasmid',\n",
              " 866: 'exp',\n",
              " 867: 'computer',\n",
              " 868: 'unit',\n",
              " 869: 'carcinoma',\n",
              " 870: 'syndrome',\n",
              " 871: 'caused',\n",
              " 872: 'interest',\n",
              " 873: 'carried',\n",
              " 874: 'class',\n",
              " 875: 'scores',\n",
              " 876: 'inc',\n",
              " 877: 'future',\n",
              " 878: 'disorders',\n",
              " 879: 'black',\n",
              " 880: 'studied',\n",
              " 881: 'directly',\n",
              " 882: 'acta',\n",
              " 883: 'june',\n",
              " 884: 'upon',\n",
              " 885: 'able',\n",
              " 886: 'supported',\n",
              " 887: 'improvement',\n",
              " 888: 'upper',\n",
              " 889: 'maximum',\n",
              " 890: 'global',\n",
              " 891: 'selection',\n",
              " 892: 'apoptotic',\n",
              " 893: 'es',\n",
              " 894: 'resulting',\n",
              " 895: 'together',\n",
              " 896: 'service',\n",
              " 897: 'chain',\n",
              " 898: 'prior',\n",
              " 899: '\\x1a\\x1a\\x1a\\x1a\\x1a\\x1a',\n",
              " 900: 'space',\n",
              " 901: 'expected',\n",
              " 902: 'fact',\n",
              " 903: 'actin',\n",
              " 904: 'renal',\n",
              " 905: 'original',\n",
              " 906: 'genetic',\n",
              " 907: 'college',\n",
              " 908: 'transfer',\n",
              " 909: 'ti',\n",
              " 910: 'recently',\n",
              " 911: 'bp',\n",
              " 912: 'rt',\n",
              " 913: 'molecules',\n",
              " 914: 'skin',\n",
              " 915: 'jbc',\n",
              " 916: 'media',\n",
              " 917: 'numbers',\n",
              " 918: 'plants',\n",
              " 919: 'statistically',\n",
              " 920: 'food',\n",
              " 921: 'correlation',\n",
              " 922: 'often',\n",
              " 923: 'suggested',\n",
              " 924: 'project',\n",
              " 925: 'propofol',\n",
              " 926: 'lead',\n",
              " 927: 'advanced',\n",
              " 928: 'immune',\n",
              " 929: 'daily',\n",
              " 930: 'source',\n",
              " 931: 'phys',\n",
              " 932: 'identification',\n",
              " 933: 'individuals',\n",
              " 934: 'lps',\n",
              " 935: 'collected',\n",
              " 936: 'methylation',\n",
              " 937: 'evaluated',\n",
              " 938: 'mitochondrial',\n",
              " 939: 'pbs',\n",
              " 940: 'exercise',\n",
              " 941: 'reduce',\n",
              " 942: 'market',\n",
              " 943: 'adults',\n",
              " 944: 'diseases',\n",
              " 945: 'therapeutic',\n",
              " 946: 'image',\n",
              " 947: 'gel',\n",
              " 948: 'resulted',\n",
              " 949: 'necessary',\n",
              " 950: 'expressing',\n",
              " 951: 'strain',\n",
              " 952: 'trans',\n",
              " 953: 'suggests',\n",
              " 954: 'di',\n",
              " 955: 'assays',\n",
              " 956: 'lee',\n",
              " 957: 'program',\n",
              " 958: 'helvetica',\n",
              " 959: 'input',\n",
              " 960: 'percentage',\n",
              " 961: 'assess',\n",
              " 962: 'indicates',\n",
              " 963: 'extracts',\n",
              " 964: 'chemical',\n",
              " 965: 'stability',\n",
              " 966: 'every',\n",
              " 967: 'acad',\n",
              " 968: 'arch',\n",
              " 969: 'conclusion',\n",
              " 970: 'confirmed',\n",
              " 971: 'monitoring',\n",
              " 972: 'systematic',\n",
              " 973: 'tnf',\n",
              " 974: 'basic',\n",
              " 975: 'generated',\n",
              " 976: 'conclusions',\n",
              " 977: 'strong',\n",
              " 978: 'complexes',\n",
              " 979: 'adult',\n",
              " 980: 'ni',\n",
              " 981: 'reference',\n",
              " 982: 'economic',\n",
              " 983: 'contact',\n",
              " 984: 'transfection',\n",
              " 985: 'neurons',\n",
              " 986: 'sodium',\n",
              " 987: 'laboratory',\n",
              " 988: 'red',\n",
              " 989: 'final',\n",
              " 990: 'acids',\n",
              " 991: 'induces',\n",
              " 992: 'components',\n",
              " 993: 'modified',\n",
              " 994: 'gfp',\n",
              " 995: 'sub',\n",
              " 996: 'investigated',\n",
              " 997: 'reports',\n",
              " 998: 'experience',\n",
              " 999: 'meta',\n",
              " 1000: 'si',\n",
              " ...}"
            ]
          },
          "metadata": {},
          "execution_count": 81
        }
      ],
      "source": [
        "reverse_word_index"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 82,
      "id": "866fb8a1",
      "metadata": {
        "id": "866fb8a1"
      },
      "outputs": [],
      "source": [
        "def decode(sequence):\n",
        "    return \" \".join([reverse_word_index.get(idx, \"?\") for idx in sequence])  "
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 83,
      "id": "571dba7b",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "571dba7b",
        "outputId": "c3dee2bf-06c2-4a7d-d2fb-92c0a349e9d4"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[262, 2290, 2, 1834, 54, 2230, 3, 439, 86, 2, 1, 317, 2, 22, 210, 11, 5, 2996, 2668, 1732, 1309, 22, 210, 62, 71, 143, 6, 26, 4, 2522, 2, 2967, 733, 1541, 40, 2341, 2427, 1, 317, 2, 22, 210, 1670, 1602, 205, 26, 510, 6, 1444, 61, 1158, 441, 6, 22, 210, 1, 1883, 646, 2, 22, 210, 62, 1, 2041, 6, 2890, 22, 687, 11, 2750, 3064, 682, 189, 682, 8461, 458, 1265, 16, 831, 4955, 21633, 1792, 2, 5689, 1496, 429, 119, 16, 2732, 7814, 3382, 1503, 1503, 716, 55599, 345, 735, 55599, 657, 907, 28282, 381, 2616, 738, 10645, 4944, 58, 683, 10645, 381, 7721, 5088, 55599, 2815, 1327, 13216, 2265, 381, 8680, 8608, 11831, 3, 1750, 657, 513, 55599, 657, 907, 28282, 381, 70283, 12, 495, 13, 95, 14, 176, 798, 114, 15, 656, 208, 2077, 1462, 102, 1, 6395, 4354, 1792, 14243, 12, 536, 4, 1, 1943, 429, 1792, 224, 3, 48, 12, 2760, 1669, 13, 1, 1631, 7814, 1792, 9781, 12, 4124, 116, 1, 14243, 709, 6, 350, 5, 156, 2732, 7814, 1792, 1631, 7814, 3, 6395, 4354, 1792, 2009, 14243, 22, 156, 2732, 709, 60, 6756, 1, 1792, 2333, 3, 7837, 2064, 2, 14243, 3, 60, 4668, 3115, 176, 798, 271, 1, 5672, 3184, 3, 14158, 1792, 8551, 19, 16929, 656, 253, 1303, 2, 14243, 3, 364, 1943, 429, 351, 22, 2009, 14243, 709, 12, 536, 4, 1, 1792, 224, 2, 757, 1280, 113, 1943, 429, 1, 400, 46, 457, 13, 1, 2009, 14243, 60, 4668, 841, 1, 1792, 1156, 3, 3184, 3, 1023, 22529, 1, 620, 2, 656, 208, 2077, 6, 1, 1792, 335, 1545, 5689, 1496, 1943, 7814, 3382, 6395, 4354, 1792, 14243, 1631, 7814, 1792, 9781, 1496, 429, 42, 779, 5689, 1496, 1943, 10, 1, 949, 1496, 1070, 6, 841, 1, 202, 2, 113, 4029, 941, 1, 1496, 1562, 3, 1718, 1, 113, 2318, 4, 658, 225, 258, 346, 6964, 873, 236, 2462, 117, 3, 346, 1792, 161, 7, 5689, 1496, 2472, 119, 16, 1, 525, 1496, 728, 118, 3, 3627, 3132, 14, 649, 3, 536, 4, 1, 224, 2, 10434, 1496, 687, 7, 1, 657, 113, 1, 1792, 709, 2, 7814, 3382, 12, 7116, 88, 1605, 4, 346, 2927, 5275, 1, 2712, 2881, 2, 109, 7814, 3382, 2769, 6, 841, 1, 3419, 2, 283, 709, 21, 176, 1132, 1, 2732, 709, 60, 5139, 88, 1792, 78, 22, 2063, 2, 2732, 1792, 1228, 271, 7814, 3382, 60, 26, 9562, 27205, 316, 15, 1, 195, 642, 3, 657, 648, 3, 60, 9077, 1, 867, 9043, 59, 2931, 6, 3115, 1, 321, 1792, 648, 48, 12, 2057, 271, 1, 1943, 1792, 648, 119, 16, 1, 525, 1562, 3, 2318, 3132, 7, 1, 1700, 113, 4, 3, 1, 906, 709, 2039, 6395, 4354, 1792, 14243, 1631, 7814, 1792, 9781, 3, 82, 3382, 1792, 709, 14, 536, 4, 22, 650, 1, 117, 317, 1130, 1863, 114, 15, 505, 6, 2503, 1, 656, 208, 258, 15, 6, 941, 1, 620, 2, 656, 253, 6, 1, 1792, 70, 505, 6, 1439, 17363, 2, 1, 1792, 3419, 948, 19, 1, 8347, 253, 2, 656, 3, 815, 1, 1943, 429, 88, 437, 3, 5001, 258, 316, 6, 1, 441, 376, 1, 2732, 1792, 714, 2, 7814, 3382, 119, 16, 14243, 3, 9781, 1631, 7814, 3, 6395, 4354, 1792, 2009, 14243, 10, 2760, 1669, 4, 22, 210, 3, 10, 536, 4, 1, 1943, 429, 1792, 118, 2, 1, 212, 1700, 113, 9, 648, 5121, 3, 1378, 5, 974, 118, 2, 1943, 1, 974, 2216, 2, 1144, 1496, 714, 10, 13, 209, 1, 12443, 2, 9307, 1, 2815, 5126, 2318, 1, 1496, 728, 205, 26, 383, 15, 776, 15, 420, 54, 1, 1792, 2, 1496, 224, 1, 113, 5126, 1156, 3, 1107, 60, 26, 804, 22, 210, 4866, 21, 3698, 1, 4182, 1943, 728, 648, 2, 757, 1280, 113, 1, 752, 375, 2, 1, 648, 10, 6, 1116, 1, 3907, 1496, 429, 6, 14406, 1, 248, 1171, 209, 2318, 3, 3627, 7094, 102, 1, 1943, 429, 10, 1023, 517, 1, 1943, 728, 3, 130, 2815, 1496, 728, 139, 211, 191, 2, 2505, 113, 1496, 15, 170, 1, 456, 332, 1943, 429, 139, 335, 4, 101, 113, 678, 202, 3, 1496, 728, 4, 1, 1112, 431, 2, 1496, 429, 26710, 13, 1, 757, 1280, 113, 62, 56, 1280, 14244, 3, 111, 6738, 62, 7072, 757, 2151, 140, 1, 1943, 728, 60, 26, 368, 15, 81, 9, 9, 9, 9, 81, 16799, 179380, 56, 56, 33, 42, 179381, 56, 81, 266, 49646, 7038, 7, 1, 3708, 1627, 2, 1, 23498, 1280, 6738, 131722, 7038, 7, 76, 1943, 26238, 728, 2, 1, 3708, 1627, 2, 1, 23498, 1280, 6738, 78813, 7038, 7, 1, 130, 1943, 115, 2, 1, 3708, 1627, 2, 1, 23498, 1280, 6738, 3, 10, 671, 15, 179382, 179383, 179384, 28, 20, 49646, 9, 81, 266, 2834, 6588, 24, 277, 1, 113, 1839, 89, 1, 152, 1943, 3870, 3, 1, 1943, 429, 2, 2151, 15, 170, 3543, 10, 5, 11574, 167, 49, 14245, 1, 46, 6, 1, 8887, 26239, 2406, 8047, 23185, 1808, 10, 1, 3627, 2, 113, 21, 3870, 32, 10, 1, 2318, 3132, 1, 1789, 2318, 2, 113, 1171, 38, 1, 1792, 224, 2, 2009, 14243, 974, 8552, 1, 974, 1911, 2, 2009, 14243, 10, 13, 16, 1, 812, 2, 7837, 2064, 2, 1496, 429, 9781, 10, 536, 4, 1, 1549, 208, 2077, 2, 14243, 6, 841, 1, 1792, 99, 1, 804, 709, 10, 109, 4, 72, 20865, 5, 1, 1792, 2333, 2, 14243, 24, 25798, 4, 1, 974, 14243, 1, 1650, 1607, 10, 5025, 316, 6, 1, 18157, 680, 38459, 3, 2764, 20131, 680, 46995, 4, 2009, 14243, 1987, 2, 1, 2062, 728, 1, 38459, 3, 46995, 24, 13361, 8, 3367, 54, 1, 1943, 351, 900, 10, 1958, 116, 30, 1794, 3, 43, 602, 1378, 24, 2459, 4, 966, 12496, 1, 1650, 1607, 10, 671, 8, 12496, 579, 18157, 3, 2764, 20131, 4, 22, 630, 1, 1792, 1156, 60, 26, 804, 2355, 1, 1360, 2, 18157, 680, 38459, 24, 2864, 69, 1255, 1, 1476, 1, 89, 1664, 10, 1, 1274, 1, 18157, 1283, 10, 48, 569, 13, 209, 1, 2318, 3, 3627, 17830, 5, 332, 1496, 429, 10, 70284, 6, 1, 728, 1792, 1, 20131, 680, 46995, 10, 3014, 54, 966, 6291, 8462, 3, 110, 1283, 7038, 7, 1, 5322, 20131, 13217, 2, 39725, 19, 1, 3708, 1496, 429, 2, 3687, 1627, 6, 1, 13218, 1496, 429, 2, 2524, 1627, 229, 1, 779, 2, 9781, 2355, 21370, 1, 2062, 728, 648, 3, 55600, 1, 3845, 2, 1378, 5617, 5275, 1, 9781, 2881, 4, 1031, 648, 3698, 48, 13219, 1, 620, 2, 1457, 1378, 3, 211, 1, 2062, 3184, 3, 351, 2312, 38, 1, 1792, 166, 2, 1627, 1496, 429, 10, 804, 3, 3526, 374, 1496, 429, 253, 69, 1664, 4925, 6951, 131723, 22, 16800, 166, 139, 335, 4, 5, 382, 115, 2, 1457, 1378, 316, 6, 10346, 2318, 3132, 1, 166, 536, 4, 22, 210, 139, 285, 1, 1496, 429, 2, 966, 1627, 316, 6, 1, 1496, 728, 1792, 174, 54, 966, 6395, 4354, 6291, 35031, 1, 2801, 2216, 10, 15, 859, 9, 9, 9, 9, 9, 173, 173, 9, 403, 179385, 42, 42, 179386, 64468, 179387, 179388, 9, 81, 266, 4, 1, 29, 2447, 351, 900, 1, 3708, 1631, 1320, 10, 64469, 32333, 49, 13671, 7038, 7, 1, 1496, 2472, 2, 966, 1627, 64469, 70285, 10, 110, 1471, 1, 1316, 4742, 351, 76, 1631, 11302, 10, 368, 15, 179389, 42, 1025, 104383, 1342, 50, 4742, 351, 10, 143, 1, 179390, 10, 5, 1862, 568, 1, 890, 1316, 4742, 351, 10, 368, 15, 179391, 104384, 3, 24, 5127, 255, 3, 24, 1925, 1944, 3, 24, 72, 364, 188, 25, 69, 3, 24, 468, 46996, 179392, 81, 266, 25399, 10, 5025, 2987, 16, 109, 354, 802, 3, 3136, 900, 73, 10, 1, 10086, 188, 1, 1274, 73, 3, 25399, 24, 1, 647, 1, 1631, 890, 3136, 3353, 10, 2661, 1, 721, 1, 1631, 763, 3136, 3353, 10, 4, 22, 630, 1, 4742, 1378, 24, 2261, 11, 1, 763, 3, 890, 1316, 1378, 54, 76, 6291, 258, 48, 8770, 5, 4742, 166, 7, 1, 1496, 429, 351, 109, 19, 1, 905, 14243, 1, 2009, 14243, 224, 10, 106, 4, 91, 1, 1641, 2, 602, 787, 1, 1641, 2, 602, 787, 10, 1, 212, 15, 20, 23499, 1433, 19, 76, 1496, 12496, 2, 76, 1803, 1627, 4125, 154, 2380, 3142, 1, 1496, 429, 3, 908, 19, 76, 12496, 6, 633, 91, 457, 1, 1792, 6291, 2, 6395, 4354, 1, 5657, 308, 2, 1792, 1, 224, 44898, 31, 75, 2987, 16, 1, 6291, 115, 85, 67, 3390, 16, 1, 1792, 174, 2, 1496, 728, 102, 48, 3753, 6, 5, 1100, 6291, 115, 153, 1, 1496, 728, 2, 351, 50, 1476, 329, 140, 1, 2062, 24575, 1650, 2333, 3, 20131, 2801, 2333, 316, 6, 38459, 3, 46995, 1, 23499, 24, 30786, 6, 3142, 1, 12496, 8, 88, 20131, 3, 721, 18157, 3, 111, 6395, 1147, 37, 1755, 6395, 2976, 54, 76, 6291, 152, 2, 61, 1, 24227, 1378, 24, 6977, 140, 1, 52244, 24, 3014, 316, 6, 1, 671, 1496, 728, 3, 9781, 6425, 6, 2990, 1, 1496, 351, 6, 8578, 1, 104385, 202, 1, 1650, 1607, 2, 6395, 56, 16043, 19, 3708, 12496, 2, 76, 1627, 6, 13218, 12496, 2, 633, 1627, 60, 26, 671, 15, 9, 9, 9, 81, 9, 9, 9, 9, 9, 9, 9, 1120, 2546, 179393, 179394, 38459, 56, 42, 6427, 56, 56, 42, 81, 81, 9, 9, 81, 266, 173, 1057, 1, 185, 2, 20131, 680, 3, 18157, 680, 1255, 154, 24, 416, 1175, 34089, 1396, 1, 2016, 2, 1, 420, 49647, 6, 49, 1, 6395, 56, 60, 908, 19, 3708, 12496, 890, 20131, 9308, 2333, 33, 179395, 33, 548, 9, 9, 81, 81, 266, 81, 10, 1, 5322, 769, 2, 20131, 38460, 31484, 81, 9, 9, 9, 9, 1120, 179396, 3876, 9, 266, 393, 1, 130, 20131, 10, 5, 249, 1014, 33, 7038, 7, 1, 115, 2, 23499, 49, 11302, 1, 1316, 1378, 104386, 10, 1, 1496, 728, 366, 11, 1, 6395, 2976, 73, 10, 1, 3420, 1496, 728, 2900, 143, 1, 656, 2, 2009, 14243, 24, 416, 12370, 6, 48, 205, 26, 10820, 13, 1, 1549, 2077, 2, 2009, 14243, 24985, 620, 1, 1792, 224, 776, 75, 1, 7814, 115, 205, 26, 181, 316, 6, 648, 501, 48, 139, 5565, 1, 5362, 9, 46, 59, 3, 593, 3638, 6, 1, 212, 757, 1280, 113, 12370, 6, 1, 2009, 14243, 335, 10, 133, 6, 1, 82, 72, 109, 2769, 4, 72, 804, 14243, 2769, 24, 2760, 1669, 4, 1, 981, 3, 5421, 52, 88, 2881, 84, 906, 709, 3, 154, 24, 72, 721, 804, 2769, 2, 6395, 4354, 1792, 19, 1, 46, 59, 1269, 1, 1943, 1792, 70, 2, 2009, 14243, 3, 72, 142, 656, 24, 592, 15, 179397, 32, 32, 3615, 179398, 9, 81, 11898, 131724, 32, 32, 3615, 131725, 9, 81, 15, 179399, 23, 23, 179400, 9, 81, 11898, 131724, 23, 23, 2387, 131725, 9, 81, 1, 142, 70, 24, 106, 4, 1, 3021, 15, 215, 3, 48, 60, 26, 3237, 13, 5, 2009, 14243, 8770, 5, 4742, 351, 6, 1, 798, 2760, 1669, 4, 6, 5, 1100, 1132, 1, 2009, 14243, 707, 1, 2318, 2, 351, 3, 55600, 1, 3845, 2, 351, 258, 1, 1496, 429, 60, 26, 366, 6, 9888, 38, 1, 2009, 14243, 1549, 2077, 52, 361, 620, 84, 1, 1120, 1, 529, 1587, 2, 22, 10, 1, 3609, 496, 2, 9781, 3, 14243, 16, 1, 76, 737, 1, 591, 4, 1316, 12496, 13425, 1, 104385, 202, 16, 1, 82, 1, 8347, 188, 13219, 1, 6643, 351, 3, 27697, 1, 3698, 224, 23, 1, 7655, 2, 7837, 2064, 16435, 1, 2451, 2, 38459, 3, 46995, 4, 22, 630, 1, 635, 2, 680, 501, 3602, 1, 709, 1156, 3, 6, 5, 1692, 1132, 13425, 1, 104385, 202, 29, 1, 2459, 1496, 429, 1378, 2, 2009, 14243, 24, 31, 78814, 154, 139, 26, 993, 316, 6, 1, 1792, 174, 54, 966, 6291, 3367, 1, 3582, 2, 351, 60, 26, 17507, 33, 1, 1943, 1228, 2009, 14243, 3, 143, 52, 1, 212, 1496, 728, 85, 1, 3136, 89, 10, 4097, 305, 109, 2318, 3, 3627, 7094, 1, 2769, 60, 26, 133, 3237, 19, 1, 335, 1, 2009, 14243, 10, 37, 499, 887, 120, 42, 5, 32, 9, 2834, 142, 2, 1943, 1228, 266, 104387, 104388, 104389, 104390, 120, 187, 131726, 2834, 142, 2, 1943, 1228, 266, 104387, 104388, 104389, 104390, 120, 403, 131726, 2834, 142, 2, 1943, 1228, 266, 104387, 104388, 104389, 104390, 9, 969, 1, 193, 2, 7814, 3382, 1173, 88, 156, 161, 7, 1, 1943, 429, 1792, 21, 231, 1, 648, 2, 1943, 429, 1792, 11426, 7, 757, 3889, 1280, 3889, 3, 1700, 113, 10, 2057, 4, 1, 974, 603, 2, 1031, 1171, 4, 22, 210, 1, 687, 118, 2, 1943, 10, 75, 536, 4, 1, 12114, 17, 432, 2, 1031, 1171, 3, 10, 75, 68, 16, 8462, 1, 152, 770, 89, 3, 1496, 429, 4, 1, 1215, 89, 1664, 2, 1031, 1171, 85, 7, 176, 382, 25799, 12114, 114, 15, 1, 900, 4572, 21371, 2815, 37158, 113, 10917, 113, 3, 82, 382, 2521, 12114, 154, 61, 52, 1, 7426, 473, 2, 332, 89, 2730, 3, 179401, 1171, 258, 7, 22, 2063, 2, 12114, 48, 10, 16929, 6, 2875, 1, 450, 1496, 728, 118, 3, 1, 889, 3627, 118, 6, 2126, 1, 1943, 429, 48, 10, 6148, 6, 5349, 88, 1605, 6, 1955, 2, 1943, 429, 1792, 1987, 1, 2033, 603, 2, 11196, 23885, 981, 716, 70286, 2613, 49648, 526, 179402, 1792, 2, 141, 416, 119, 16, 3930, 2732, 714, 103, 2, 141, 3, 863, 345, 299, 104391, 4203, 2236, 64470, 4564, 179403, 3826, 1792, 648, 2, 2521, 8489, 119, 16, 7814, 3382, 709, 867, 1755, 3248, 432, 299, 526, 179404, 3975, 572, 9008, 55601, 2732, 709, 16, 1050, 38461, 1434, 5239, 648, 4012, 2, 2265, 735, 2, 345, 299, 3975, 179405, 5088, 179406, 2236, 572, 1462, 1334, 2, 1, 999, 10864, 2769, 7, 9009, 58, 3, 687, 299, 39, 70287, 33, 78815, 57, 104392, 156, 166, 6, 4182, 1, 5689, 1496, 728, 2, 757, 1280, 432, 2318, 657, 113, 1239, 299, 20, 179407, 57, 104392, 33, 78815, 30, 131727, 156, 166, 6, 4182, 1, 5689, 1496, 728, 2, 757, 1280, 432, 64, 6395, 4354, 1792, 2318, 657, 113, 1239, 299, 33, 78815, 30, 131727, 57, 104392, 656, 1303, 2, 1, 6395, 4354, 709, 536, 4, 5689, 1496, 1792, 103, 2, 3930, 3248, 299, 35032, 20, 179408, 20, 179409, 906, 2769, 3, 10474, 10475, 1326, 7, 1316, 621, 340, 2318, 657, 3, 113, 1239, 299, 6459, 78816, 3709, 131728, 526, 6978, 1462, 1792, 2, 5689, 1496, 429, 119, 16, 2039, 7282, 58, 3, 8172, 58, 299, 1094, 6588, 2009, 14243, 13289, 14243, 6588, 6588, 1094, 6588, 2009, 14243, 13289, 14243, 6588, 6588, 1094, 6588, 2009, 14243, 13289, 14243, 6588, 6588]\n",
            "science notice of retraction after careful and considered review of the content of this paper by a duly constituted expert committee this paper has been found to be in violation of ieee's publication principles we hereby retract the content of this paper reasonable effort should be made to remove all past references to this paper the presenting author of this paper has the option to appeal this decision by contacting tpii ieee org ieee sixth international conference on natural computation icnc optimization of preventive maintenance period based on hybrid swarm intelligence sa sa ma ordnance technology institute ordnance engineering college shijiazhuang china hong zhang xian satellite control center xian china tao feng ordnance equipment supply depot beijing china jia xue optics and electronic engineering department ordnance engineering college shijiazhuang china abstractit was analyzed that there were some problems such as parameters value settings etc when the ant colony optimization aco was applied in the pm period optimization process and it was put forward that the particle swarm optimization pso was brought into the aco algorithm to form a new hybrid swarm optimization particle swarm and ant colony optimization ps aco this new hybrid algorithm can modify the optimization rules and geographic division of aco and can partly solve some problems about the worse precision and inefficient optimization coming from unsuitable parameters values setting of aco and random pm period solution this ps aco algorithm was applied in the optimization process of series parallel system pm period the experimental data shows that the ps aco can partly improve the optimization efficiency and precision and relatively weaken the influence of parameters value settings to the optimization result keywords preventive maintenance pm swarm intelligence ant colony optimization aco particle swarm optimization pso maintenance period i introduction preventive maintenance pm is the necessary maintenance mode to improve the rate of system utilization reduce the maintenance costs and enhance the system reliability in recent years so many scholars carried out comprehensive research and many optimization methods for preventive maintenance periods based on the least maintenance cost model and availability restriction were provided and applied in the process of assistant maintenance decision for the engineering system the optimization algorithm of swarm intelligence was paid more attention in many fields utilizing the respective advantages of different swarm intelligence algorithms to improve the defect of single algorithm at some extent the hybrid algorithm can realize more optimization effect this kind of hybrid optimization strategies about swarm intelligence can be refined flexibly according as the difference application and engineering problem and can utilize the computer aided analysis tools to solve the complex optimization problem it was discussed about the pm optimization problem based on the least costs and reliability restriction for the compound system in and the genetic algorithm ga ant colony optimization aco particle swarm optimization pso and other intelligence optimization algorithm were applied in this field the research content mainly includes such as how to define the parameters value so as to reduce the influence of parameters values to the optimization results how to get rid of the optimization defect resulted from the stochastic values of parameters and make the pm period more available and accurately so according to the references above the hybrid optimization strategy of swarm intelligence based on aco and pso particle swarm and ant colony optimization ps aco is put forward in this paper and is applied in the pm period optimization model of the same compound system \u001a problem modelling and solutions a basic model of pm the basic rule of making maintenance strategy is that under the prerequisite of satisfying the equipment operational reliability the maintenance cost should be reduced as much as possible after the optimization of maintenance process the system operational efficiency and benefit can be improved this paper aims at solving the minimize pm cost problem of series parallel system the central point of the problem is to find the proper maintenance period to assure the normal operation under reliability and availability restrictions when the pm period is relatively short the pm cost and total equipment maintenance cost will increase because of frequent system maintenance as well the relative long pm period will result in high system failure rate and maintenance cost in the later part of maintenance period supposing that the series parallel system has k parallel subsystems and each subsystem has ek series devices then the pm cost can be expressed as \u001a\u001a \u001a \u001a \u001a \u001a \u001a\u001a ata kiecnc k k e i kiepm k \u001a\u001a where kie stands for the ith device of the kth parallel subsystem kiec stands for one pm settled cost of the ith device of the kth parallel subsystem kien stands for the total pm number of the ith device of the kth parallel subsystem and is calculated as kiet kietkiet floorn p m kie \u001a \u001a\u001a where tm tp are respectively the system working time the first pm moment and the pm period of devices as well floor is a matlab function which rounds the data to the nearest integers towards minus infinity ta is the availability of system at moment t is the reliability restriction the minimum reliability of system operation b the optimization process of ps aco basic thoughts the basic thought of ps aco is that on the basis of geographic division of maintenance period pso is applied in the parameter value settings of aco to improve the optimization effects the improved algorithm is different in two respects a the optimization rules of aco are ameliorated in the basic aco the transition probability is decided according to the visibility matrix jip and residual pheromone matrix ji\u001a in ps aco considering of the calculation cost the jip and ji\u001a are dealt with accordingly after the pm solution space is divided into n parts and l initial solutions are chosen in every subspace the transition probability is calculated with subspace average visibility and residual pheromone in this way the optimization efficiency can be improved effectively the elements of visibility matrix jip are restricted between generally the longer the time interval is the larger the visibility element is it means that under the reliability and availability restricts a long maintenance period is propitious to the cost optimization the pheromone matrix ji\u001a is updated after every iteration optimizing and its element stands for the decay pheromone summation of jumping from the ith maintenance period of former device to the jth maintenance period of latter device thus the introduction of pso effectively solves the calculation cost problem and enriches the diversity of solutions meanwhile utilizing the pso advantages in continuous problem solving it avoids the influence of reserved solutions and increase the calculation precision and solution validity b the optimization method of device maintenance period is improved and select several maintenance period values between interval lb ub stochastically this optional method will result in a large number of reserved solutions according to rigorous reliability restriction the method applied in this paper will change the maintenance period of every device according to the maintenance cost optimization level after every ant colony iteration finishes the update rule is as follows \u001a \u001a \u001a \u001a \u001a \u001a\u001a\u001a \u001a\u001a\u001a \u001a iii ibest i i bestii vxx xgrc xprcvv \u001a \u001a\u001a where in the d dimension solution space the ith particle location is idiii xxxx which practically stands for the maintenance periods of every device idiii vvvv is its velocity the optimal feasible solution one particle finds is expressed as idii i best bbbp once no feasible solution is found the ibestp is a zero vector the global optimal feasible solution is expressed as dbest gggg and are accelerated factors and are always assigned and are two random factor s between and are independent maxmax vvvi \u001a\u001a where maxv is decided depending on different target functions and searching space w is the inertia factor the larger w and maxv are the greater the particle global searching capability is otherwise the better the particle local searching capability is in this way the feasible solutions are changed by the local and global optimal solutions after one iteration so it proposes a feasible method for the maintenance period solution different from the original aco the ps aco process is shown in figure the determination of initial points the determination of initial points is the same as m ants start from one maintenance subspace of one identical device firstly they randomly choose the maintenance period and transfer from one subspace to another figure shows the optimization iteration of ant colony the termination conditions of optimization the process terminates not only depending on the iteration number but also lying on the optimization level of maintenance cost when it comes to a certain iteration number if the maintenance cost of solution no longer changes then the calculation stops transition rules and pheromone update rules according to jip and ji\u001a the ants are apt to choose the subspace with more pheromone and better visibility and each ant forms an integrated ant route after one iteration first of all the improper solutions are eliminated then the pheromones are updated according to the calculated maintenance cost and pso helps to optimize the maintenance solution to accelerate the constringency rate the transition probability of ant k transfers from ith subspace of one device to jth subspace of another device can be calculated as \u001a \u001a \u001a \u001a\u001a \u001a \u001a \u001a \u001a \u001a \u001a \u001a others jj uipui jipji jip k i ju k k i \u001a\u001a \u001a\u001a \u001a \u001a \u001a\u001a where \u001a\u001a\u001a represent the ratio of pheromone matrix and visibility matrix generally they are set equal kij represents the list of the possible subspaces to which the ant k can transfer from ith subspace global pheromone updating rules e ijijijij e \u001a\u001a\u001a\u001a\u001a \u001a \u001a \u001a\u001a \u001a\u001a where \u001a\u001a is the decay degree of pheromone ijij wq \u001a\u001a \u001a \u001a \u001a \u001a others routeoptimalthetobelongjiwqe ij \u001a where q the total pheromone is a fixed constant e stands for the number of ants which finds the optimal solutions ijw is the maintenance cost determined by the ant route w is the optimum maintenance cost ever found the parameters of ps aco are set referring to it should be emphasized that the parameter settings of ps aco wont influence the optimization process much only the swarm number should be increased according to problem scale it will satisfy the demands \u001a data analysis and contrast applying to the same series parallel system referring to the ps aco result is compared to the other two different algorithms in two improved aco algorithms are put forward in the reference and apparently have more advantages than genetic algorithm and they are two better improved algorithms of ant colony optimization from the data analysis comparing the pm optimization results of ps aco and two comparison parameters are defined as acopsas t t tt asacopsr \u001a \u001a\u001a acs acopsacs t t tt acsacopsr \u001a \u001a\u001a as pasoas c c ccasacopsr \u001a \u001a\u001a acs acopsacs c c cc acsacopsr \u001a \u001a\u001a the comparison results are shown in the tables as following and it can be concluded that a ps aco proposes a feasible solution to the problems put forward in to a certain extent the ps aco increases the reliability of solution and enriches the diversity of solution so the maintenance period can be determined to reasonably b the ps aco parameter settings have less influence than the others the main reason of this is the complementary interaction of pso and aco on the one hand the search in optimal subspace accelerates the constringency rate on the other the stochastic factor avoids the inferior solution and simplifies the solving process c the adoption of geographic division expands the contents of jip and ji\u001a in this way the decrease of matrix scale improves the algorithm efficiency and to a great extent accelerates the constringency rate d the chosen maintenance period solutions of ps aco are not unalterable they will be modified according to the optimization level after every iteration accordingly the uncertainty of solution can be weakened e the pm strategies ps aco and found have the same maintenance cost but the searching time is shorter given different reliability and availability restrictions the algorithms can be compared concluded from the result the ps aco is an effective improvement table i a t \u001a tm comparison of pm strategies where asacopsrt acsacopsrt asacopsrc acsacopsrc table ii wrv\u001a tm comparison of pm strategies where asacopsrt acsacopsrt asacopsrc acsacopsrc table iii wrv\u001a tm comparison of pm strategies where asacopsrt acsacopsrt asacopsrc acsacopsrc \u001a conclusion the development of swarm intelligence provides more new methods for the pm period optimization at present the problem of pm period optimization whatever for series connection parallel connection and compound system is discussed in the basic condition of continuous operation in this paper the decision model of pm is only applied in the equipments or systems of continuous operation and is only used on optimizing the first detection time and maintenance period in the task time interval of continuous operation but for some large weapon equipments such as the space flight launch equipment artillery system tank system and other large machine equipments they all have the remarkable characteristics of long time storage and intermittence operation so for this kind of equipments it is unsuitable to apply the general maintenance cost model and the maximum availability model to confirm the pm period it is worth to pay more attention to modeling of pm period optimization considering the special condition of combat readiness reference ma sasa zhao shouwei wang guangping optimization of test set based on intelligent hybrid strategy journal of test and measurement technology pp ceng yi zhu changan shen lianwan discrete optimization problem of machine layout based on swarm intelligence algorithm computer integrated manufacturing systems pp wang suxin gao li cui xiaoguang hybrid algorithm on multi depots vehicle routing problem transactions of beijing institute of technology pp gao haichang feng boqin zhu li etc reviews of the meta heuristic algorithms for tsp control and decision pp r bris e chatelet f yalaoui new method to minimize the preventive maintenance cost of series parallel systems reliability engineering system safety pp m samrout f yalaoui e chatelet n chebbo new method to minimize the preventive maintenance cost of series parallel systems using ant colony optimization reliability engineering system safety pp e chatelet n chebbo f yalaoui parameters setting of the ant colony algorithm applied in preventive maintenance optimization journal of intelligent manufacturing pp cantoni m marseguerra m zioe genetic algorithms and monte carlo simulation for optimal plant design reliability engineering and system safety pp mao zhaoyong song baowei wang peng etc optimization of preventive maintenance period based on ga fire control and command control pp component tp ps aco cps aco tp tp component tp ps aco cps aco tp tp component tp ps aco cps aco tp tp\n"
          ]
        }
      ],
      "source": [
        "decoded_text = decode(train_sequences[10])\n",
        "print(train_sequences[10])\n",
        "print(decoded_text)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 84,
      "id": "f6b6cfdc",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "f6b6cfdc",
        "outputId": "fd04139c-a3a4-4ba2-8123-90e3bbafee53"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Model: \"sequential_5\"\n",
            "_________________________________________________________________\n",
            " Layer (type)                Output Shape              Param #   \n",
            "=================================================================\n",
            " embedding_5 (Embedding)     (None, 5000, 32)          13368768  \n",
            "                                                                 \n",
            " lstm_4 (LSTM)               (None, 16)                3136      \n",
            "                                                                 \n",
            " dense_5 (Dense)             (None, 1)                 17        \n",
            "                                                                 \n",
            "=================================================================\n",
            "Total params: 13,371,921\n",
            "Trainable params: 13,371,921\n",
            "Non-trainable params: 0\n",
            "_________________________________________________________________\n"
          ]
        }
      ],
      "source": [
        "#Create LSTM model\n",
        "from tensorflow import keras\n",
        "from tensorflow.keras import layers\n",
        "\n",
        "#Embedding: https://www.tensorflow.org/tutorials/text/word_embeddings\n",
        "\n",
        "#Turns positive integers (indexes into dense vectors of fixed size. (other approach could be one-hot-encoding)\n",
        "\n",
        "#Word embeddings give us a way to use an efficient, dense representation in which similar words have\n",
        "#a similar encoding. Importantly you do not have to specify this encoding by hand. An embedding is a \n",
        "# dense vector of floating point values (the length of the vector is a parameter you specify)\n",
        "\n",
        "model = keras.models.Sequential()\n",
        "model.add(layers.Embedding(num_unique_words, 32, input_length = max_length))\n",
        "\n",
        "# The layer will take as input an integer matrix of size (batch, input_length),\n",
        "# and the largest integer (i.e. word index) in the input should be no larger than num_words (vocabulary size).\n",
        "# Now model.output_shape is (None, input_length, 32), where None is the batch dimension.\n",
        "\n",
        "#model.add(layers.LSTM(64, dropout=0.1))\n",
        "model.add(layers.LSTM(16, dropout=0.1))\n",
        "model.add(layers.Dense(1, activation=\"sigmoid\"))\n",
        "\n",
        "model.summary()\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 85,
      "id": "fa83be43",
      "metadata": {
        "id": "fa83be43"
      },
      "outputs": [],
      "source": [
        "loss = keras.losses.BinaryCrossentropy(from_logits=False)\n",
        "optim=keras.optimizers.Adam(lr=0.001)\n",
        "metrics = [\"accuracy\"]\n",
        "\n",
        "model.compile(loss=loss, optimizer=optim, metrics=metrics)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "ce5fded1",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "ce5fded1",
        "outputId": "9054f2ed-2d49-4e97-d2f2-1b82a2c37328"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Epoch 1/20\n",
            "125/125 - 606s - loss: 0.6927 - accuracy: 0.5130 - val_loss: 0.6899 - val_accuracy: 0.5666 - 606s/epoch - 5s/step\n",
            "Epoch 2/20\n",
            "125/125 - 512s - loss: 0.6308 - accuracy: 0.6395 - val_loss: 0.6481 - val_accuracy: 0.5774 - 512s/epoch - 4s/step\n",
            "Epoch 3/20\n",
            "125/125 - 513s - loss: 0.4979 - accuracy: 0.6855 - val_loss: 0.6981 - val_accuracy: 0.5720 - 513s/epoch - 4s/step\n",
            "Epoch 4/20\n",
            "125/125 - 509s - loss: 0.4388 - accuracy: 0.7082 - val_loss: 0.7220 - val_accuracy: 0.5865 - 509s/epoch - 4s/step\n",
            "Epoch 5/20\n",
            "125/125 - 513s - loss: 0.4225 - accuracy: 0.7013 - val_loss: 0.7489 - val_accuracy: 0.5853 - 513s/epoch - 4s/step\n",
            "Epoch 6/20\n",
            "125/125 - 510s - loss: 0.4170 - accuracy: 0.7138 - val_loss: 0.8334 - val_accuracy: 0.5661 - 510s/epoch - 4s/step\n",
            "Epoch 7/20\n",
            "125/125 - 512s - loss: 0.4168 - accuracy: 0.6945 - val_loss: 0.8026 - val_accuracy: 0.5836 - 512s/epoch - 4s/step\n",
            "Epoch 8/20\n",
            "125/125 - 529s - loss: 0.4124 - accuracy: 0.7130 - val_loss: 0.8132 - val_accuracy: 0.5869 - 529s/epoch - 4s/step\n",
            "Epoch 9/20\n",
            "125/125 - 523s - loss: 0.7602 - accuracy: 0.6150 - val_loss: 1.1941 - val_accuracy: 0.4917 - 523s/epoch - 4s/step\n",
            "Epoch 10/20\n",
            "125/125 - 526s - loss: 0.9575 - accuracy: 0.5033 - val_loss: 0.8825 - val_accuracy: 0.4942 - 526s/epoch - 4s/step\n",
            "Epoch 11/20\n",
            "125/125 - 523s - loss: 0.7399 - accuracy: 0.5002 - val_loss: 0.7152 - val_accuracy: 0.4971 - 523s/epoch - 4s/step\n",
            "Epoch 12/20\n",
            "125/125 - 513s - loss: 0.6851 - accuracy: 0.5138 - val_loss: 0.6955 - val_accuracy: 0.5125 - 513s/epoch - 4s/step\n",
            "Epoch 13/20\n"
          ]
        }
      ],
      "source": [
        "\n",
        "model.fit(train_padded, train_labels, epochs=20, validation_data=(val_padded, val_labels),verbose=2)\n",
        "\n"
      ]
    }
  ],
  "metadata": {
    "kernelspec": {
      "display_name": "Python 3 (ipykernel)",
      "language": "python",
      "name": "python3"
    },
    "language_info": {
      "codemirror_mode": {
        "name": "ipython",
        "version": 3
      },
      "file_extension": ".py",
      "mimetype": "text/x-python",
      "name": "python",
      "nbconvert_exporter": "python",
      "pygments_lexer": "ipython3",
      "version": "3.9.5"
    },
    "colab": {
      "name": "rnnNb.ipynb",
      "provenance": [],
      "collapsed_sections": [],
      "include_colab_link": true
    }
  },
  "nbformat": 4,
  "nbformat_minor": 5
}